{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:35:52Z","timestamp":1795044952267,"version":"4.10.2"},"reference-count":297,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82371427"],"award-info":[{"award-number":["No.82371427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82401656"],"award-info":[{"award-number":["No.82401656"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0332"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0332"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0323"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0323"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-BHX0018"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0018"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is increasingly recognized as a systemic disorder with a substantial metabolic disorder component, where the liver significantly impacts the brain via the liver-brain axis. Key mechanisms include the liver\u2019s role in clearing peripheral \u03b2-amyloid (A\u03b2), the influence of hepatic enzymes and metabolites on cognitive decline, and the systemic effects of metabolic disorders on AD progression. Hepatokines, liver-secreted proteins including fibroblast growth factor (FGF)-21, selenoprotein P (SELENOP), Fetuin-A, Midbrain astrocyte-derived neurotrophic factor (MANF), apolipoprotein J (ApoJ), sex hormone-binding globulin (SHBG), Adropin and Angiopoietin-like protein 3 (ANGPTL3), could regulate insulin sensitivity, lipid metabolism, oxidative stress, immune responses, and neurotrophic support. These pathways are closely linked to core AD pathologies, including A\u03b2 aggregation, tau hyperphosphorylation, neuroinflammation, oxidative stress and mitochondrial dysfunction. Lifestyle interventions, including exercise and dietary modifications, that regulate hepatokines expression may offer novel preventive and therapeutic strategies for AD. This review synthesizes current knowledge on the liver-brain crosstalk in AD, emphasizing the mechanistic role of liver in bridging metabolic dysfunction with neurodegeneration and underscores the diagnostic and therapeutic potential of hepatokines in addressing AD\u2019s complex pathology.<\/jats:p>","DOI":"10.1186\/s13024-025-00849-6","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T17:40:13Z","timestamp":1748454013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Bridging systemic metabolic dysfunction and Alzheimer\u2019s disease: the liver interface"],"prefix":"10.1186","volume":"20","author":[{"given":"Dan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0292-2792","authenticated-orcid":false,"given":"Xiu-Qing","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"849_CR1","doi-asserted-by":"crossref","unstructured":"Nedelec T, Couvy-Duchesne B, Monnet F, Daly T, Ansart M, Gantzer L, Lekens B, Epelbaum S, Dufouil C, Durrleman S. Identifying health conditions associated with Alzheimer\u2019s disease up to 15 years before diagnosis: an agnostic study of French and British health records. Lancet Digit Health. 2022;4:e169\u201378.","DOI":"10.1016\/S2589-7500(21)00275-2"},{"key":"849_CR2","doi-asserted-by":"crossref","unstructured":"Huang Z, Lin HWK, Zhang Q, Zong X. Targeting Alzheimer\u2019s Disease: The Critical Crosstalk between the Liver and Brain. Nutrients 2022;14(20):4298.","DOI":"10.3390\/nu14204298"},{"key":"849_CR3","doi-asserted-by":"publisher","first-page":"e111038","DOI":"10.15252\/embj.2022111038","volume":"41","author":"L Xu","year":"2022","unstructured":"Xu L, Li L, Pan CL, Song JJ, Zhang CY, Wu XH, Hu F, Liu X, Zhang Z, Zhang ZY. Erythropoietin signaling in peripheral macrophages is required for systemic \u03b2-amyloid clearance. EMBO J. 2022;41:e111038.","journal-title":"EMBO J"},{"issue":"Suppl 1","key":"849_CR4","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.14360","volume":"40","author":"G Bern\u00e1","year":"2020","unstructured":"Bern\u00e1 G, Romero-Gomez M. The role of nutrition in non-alcoholic fatty liver disease: pathophysiology and management. Liver International: Official J Int Association Study Liver. 2020;40(Suppl 1):102\u20138.","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"849_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","volume":"585","author":"T Teratani","year":"2020","unstructured":"Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, Okabayashi K, Hagihara Y, Taniki N, Kohno K, Shibata S, et al. The liver-brain-gut neural Arc maintains the T(reg) cell niche in the gut. Nature. 2020;585:591\u20136.","journal-title":"Nature"},{"key":"849_CR6","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1016\/j.peptides.2007.10.007","volume":"28","author":"H Hsuchou","year":"2007","unstructured":"Hsuchou H, Pan W, Kastin AJ. The fasting polypeptide FGF21 can enter brain from blood. Peptides. 2007;28:2382\u20136.","journal-title":"Peptides"},{"key":"849_CR7","doi-asserted-by":"publisher","first-page":"e0268592","DOI":"10.1371\/journal.pone.0268592","volume":"17","author":"F Ricken","year":"2022","unstructured":"Ricken F, Can AD, Gr\u00e4ber S, H\u00e4usler M, Jahnen-Dechent W. Post-translational modifications glycosylation and phosphorylation of the major hepatic plasma protein fetuin-A are associated with CNS inflammation in children. PLoS ONE. 2022;17:e0268592.","journal-title":"PLoS ONE"},{"key":"849_CR8","doi-asserted-by":"publisher","first-page":"1149233","DOI":"10.3389\/fendo.2023.1149233","volume":"14","author":"Z Li","year":"2023","unstructured":"Li Z, Wen X, Li N, Zhong C, Chen L, Zhang F, Zhang G, Lyu A, Liu J. The roles of hepatokine and osteokine in liver-bone crosstalk: advance in basic and clinical aspects. Front Endocrinol. 2023;14:1149233.","journal-title":"Front Endocrinol"},{"key":"849_CR9","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring HU, White MF. The role of hepatokines in NAFLD. Cell Metabol. 2023;35:236\u201352.","journal-title":"Cell Metabol"},{"key":"849_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1515\/jpem-2023-0339","volume":"37","author":"D Stein","year":"2024","unstructured":"Stein D, Ovadia D, Katz S, Brar PC. Association of hepatokines with markers of endothelial dysfunction and vascular reactivity in obese adolescents. J Pediatr Endocrinol Metabolism: JPEM. 2024;37:309\u201316.","journal-title":"J Pediatr Endocrinol Metabolism: JPEM"},{"key":"849_CR11","doi-asserted-by":"publisher","first-page":"873699","DOI":"10.3389\/fendo.2022.873699","volume":"13","author":"Y Ren","year":"2022","unstructured":"Ren Y, Zhao H, Yin C, Lan X, Wu L, Du X, Griffiths HR, Gao D. Adipokines, hepatokines and myokines: focus on their role and molecular mechanisms in adipose tissue inflammation. Front Endocrinol. 2022;13:873699.","journal-title":"Front Endocrinol"},{"key":"849_CR12","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.2337\/db14-0541","volume":"63","author":"Q Liang","year":"2014","unstructured":"Liang Q, Zhong L, Zhang J, Wang Y, Bornstein SR, Triggle CR, Ding H, Lam KS, Xu A. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting. Diabetes. 2014;63:4064\u201375.","journal-title":"Diabetes"},{"key":"849_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13195-022-01119-z","volume":"14","author":"YA Ko","year":"2022","unstructured":"Ko YA, Billheimer JT, Lyssenko NN, Kueider-Paisley A, Wolk DA, Arnold SE, Leung YY, Shaw LM, Trojanowski JQ, Kaddurah-Daouk RF, et al. ApoJ\/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14:194.","journal-title":"Alzheimers Res Ther"},{"key":"849_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41467-019-08450-4","volume":"10","author":"Y Yan","year":"2019","unstructured":"Yan Y, Rato C, Rohland L, Preissler S, Ron D. MANF antagonizes nucleotide exchange by the Endoplasmic reticulum chaperone bip. Nat Commun. 2019;10:541.","journal-title":"Nat Commun"},{"key":"849_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41598-024-51259-5","volume":"14","author":"X Zheng","year":"2024","unstructured":"Zheng X, Toyama T, Siu S, Kaneko T, Sugiura H, Yamashita S, Shimoda Y, Kanamori M, Arisawa K, Endo H, Saito Y. Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage. Sci Rep. 2024;14:682.","journal-title":"Sci Rep"},{"key":"849_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/j.2040-4603.2013.tb00506.x","volume":"3","author":"KJ Jensen","year":"2013","unstructured":"Jensen KJ, Alpini G, Glaser S. Hepatic nervous system and neurobiology of the liver. Compr Physiol. 2013;3:655\u201365.","journal-title":"Compr Physiol"},{"key":"849_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4254\/wjh.v6.i3.137","volume":"6","author":"LA Streba","year":"2014","unstructured":"Streba LA, Vere CC, Ionescu AG, Streba CT, Rogoveanu I. Role of intrahepatic innervation in regulating the activity of liver cells. World J Hepatol. 2014;6:137\u201343.","journal-title":"World J Hepatol"},{"key":"849_CR18","doi-asserted-by":"publisher","first-page":"108915","DOI":"10.1016\/j.neuropharm.2021.108915","volume":"205","author":"Y Matsubara","year":"2022","unstructured":"Matsubara Y, Kiyohara H, Teratani T, Mikami Y, Kanai T. Organ and brain crosstalk: the liver-brain axis in gastrointestinal, liver, and pancreatic diseases. Neuropharmacology. 2022;205:108915.","journal-title":"Neuropharmacology"},{"key":"849_CR19","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1172\/JCI124376","volume":"129","author":"H Shen","year":"2019","unstructured":"Shen H, Jiang L, Lin JD, Omary MB, Rui L. Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice. J Clin Investig. 2019;129:2305\u201317.","journal-title":"J Clin Investig"},{"key":"849_CR20","doi-asserted-by":"crossref","unstructured":"De C\u00f3l JP, de Lima EP, Pompeu FM, Cressoni Ara\u00fajo A, de Alvares Goulart R, Bechara MD, Laurindo LF, M\u00e9ndez-S\u00e1nchez N, Barbalho SM. Underlying mechanisms behind the Brain-Gut-Liver Axis and Metabolic-Associated fatty liver disease (MAFLD): an update. Int J Mol Sci 2024;25(7):3694.","DOI":"10.3390\/ijms25073694"},{"key":"849_CR21","doi-asserted-by":"publisher","first-page":"e72928","DOI":"10.1371\/journal.pone.0072928","volume":"8","author":"B Sigala","year":"2013","unstructured":"Sigala B, McKee C, Soeda J, Pazienza V, Morgan M, Lin CI, Selden C, Vander Borght S, Mazzoccoli G, Roskams T, et al. Sympathetic nervous system catecholamines and neuropeptide Y neurotransmitters are upregulated in human NAFLD and modulate the fibrogenic function of hepatic stellate cells. PLoS ONE. 2013;8:e72928.","journal-title":"PLoS ONE"},{"key":"849_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jare.2024.02.007","volume":"68","author":"M Meroni","year":"2025","unstructured":"Meroni M, Longo M, Paolini E, Dongiovanni P. A narrative review about cognitive impairment in metabolic Dysfunction-Associated steatotic liver disease (MASLD): another matter to face through a holistic approach. J Adv Res. 2025;68:231\u201340.","journal-title":"J Adv Res"},{"key":"849_CR23","doi-asserted-by":"publisher","first-page":"104679","DOI":"10.1016\/j.ebiom.2023.104679","volume":"93","author":"R Jiang","year":"2023","unstructured":"Jiang R, Wu J, Rosenblatt M, Dai W, Rodriguez RX, Sui J, Qi S, Liang Q, Xu B, Meng Q, et al. Elevated C-reactive protein mediates the liver-brain axis: a preliminary study. EBioMedicine. 2023;93:104679.","journal-title":"EBioMedicine"},{"key":"849_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5152\/tjg.2024.23629","volume":"35","author":"E Kaya","year":"2024","unstructured":"Kaya E, Y\u0131lmaz Y. Association of metabolic Dysfunction-Associated fatty liver disease with cognitive impairment and All-Cause dementia: A comprehensive review. Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol. 2024;35:76\u201382.","journal-title":"Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol"},{"key":"849_CR25","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1111\/liv.14161","volume":"39","author":"G Weinstein","year":"2019","unstructured":"Weinstein G, Davis-Plourde K, Himali JJ, Zelber-Sagi S, Beiser AS, Seshadri S. Non-alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle-aged adults: the Framingham study. Liver International: Official J Int Association Study Liver. 2019;39:1713\u201321.","journal-title":"Liver International: Official J Int Association Study Liver"},{"key":"849_CR26","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1002\/alz.14033","volume":"20","author":"G Weinstein","year":"2024","unstructured":"Weinstein G, Schonmann Y, Yeshua H, Zelber-Sagi S. The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc. 2024;20:5385\u201397.","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"849_CR27","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3233\/JAD-215409","volume":"86","author":"G Weinstein","year":"2022","unstructured":"Weinstein G, O\u2019Donnell A, Davis-Plourde K, Zelber-Sagi S, Ghosh S, DeCarli CS, Thibault EG, Sperling RA, Johnson KA, Beiser AS, Seshadri S. Non-Alcoholic fatty liver disease, liver fibrosis, and regional Amyloid-\u03b2 and Tau pathology in Middle-Aged adults: the Framingham study. J Alzheimer\u2019s Disease: JAD. 2022;86:1371\u201383.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jnc.15988","volume":"168","author":"PY Gao","year":"2024","unstructured":"Gao PY, Ou YN, Wang HF, Wang ZB, Fu Y, He XY, Ma YH, Feng JF, Cheng W, Tan L, Yu JT. Associations of liver dysfunction with incident dementia, cognition, and brain structure: A prospective cohort study of 431 699 adults. J Neurochem. 2024;168:26\u201338.","journal-title":"J Neurochem"},{"key":"849_CR29","doi-asserted-by":"publisher","first-page":"100992","DOI":"10.1016\/j.jhepr.2023.100992","volume":"6","author":"K Kj\u00e6rgaard","year":"2024","unstructured":"Kj\u00e6rgaard K, Daugaard Mikkelsen AC, Landau AM, Eriksen PL, Hamilton-Dutoit S, Magnusson NE, Thomsen MB, Chen F, Vilstrup H, Mookerjee RP, et al. Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammation. JHEP Reports: Innov Hepatol. 2024;6:100992.","journal-title":"JHEP Reports: Innov Hepatol"},{"key":"849_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","volume":"21","author":"T Chen","year":"2024","unstructured":"Chen T, Dai Y, Hu C, Lin Z, Wang S, Yang J, Zeng L, Li S, Li W. Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases. Fluids Barriers CNS. 2024;21:60.","journal-title":"Fluids Barriers CNS"},{"key":"849_CR31","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jnc.16025","volume":"168","author":"PY Gao","year":"2024","unstructured":"Gao PY, Ou YN, Huang YM, Wang ZB, Fu Y, Ma YH, Li QY, Ma LY, Cui RP, Mi YC, et al. Associations between liver function and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease pathology in non-demented adults: the CABLE study. J Neurochem. 2024;168:39\u201351.","journal-title":"J Neurochem"},{"key":"849_CR32","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3233\/JAD-220126","volume":"88","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Jian JM, He CY, Ren JR, Xu MY, Jin WS, Tan CR, Zeng GH, Shen YY, Chen DW, et al. The correlations of plasma Liver-Type fatty Acid-Binding protein with Amyloid-\u03b2 and Tau levels in patients with Alzheimer\u2019s disease. J Alzheimer\u2019s Disease: JAD. 2022;88:375\u201383.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR33","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ. Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease. Sci (New York NY). 2010;330:1774.","journal-title":"Sci (New York NY)"},{"key":"849_CR34","doi-asserted-by":"publisher","first-page":"101451","DOI":"10.1016\/j.arr.2021.101451","volume":"71","author":"R Ullah","year":"2021","unstructured":"Ullah R, Park TJ, Huang X, Kim MO. Abnormal amyloid beta metabolism in systemic abnormalities and Alzheimer\u2019s pathology: insights and therapeutic approaches from periphery. Ageing Res Rev. 2021;71:101451.","journal-title":"Ageing Res Rev"},{"key":"849_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s11095-006-0208-7","volume":"23","author":"C Tamaki","year":"2006","unstructured":"Tamaki C, Ohtsuki S, Iwatsubo T, Hashimoto T, Yamada K, Yabuki C, Terasaki T. Major involvement of low-density lipoprotein receptor-related protein 1 in the clearance of plasma free amyloid beta-peptide by the liver. Pharm Res. 2006;23:1407\u201316.","journal-title":"Pharm Res"},{"key":"849_CR36","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1172\/JCI81108","volume":"126","author":"SE Storck","year":"2016","unstructured":"Storck SE, Meister S, Nahrath J, Mei\u00dfner JN, Schubert N, Di Spiezio A, Baches S, Vandenbroucke RE, Bouter Y, Prikulis I, et al. Endothelial LRP1 transports amyloid-\u03b2(1\u201342) across the blood-brain barrier. J Clin Investig. 2016;126:123\u201336.","journal-title":"J Clin Investig"},{"key":"849_CR37","doi-asserted-by":"publisher","first-page":"106570","DOI":"10.1016\/j.nbd.2024.106570","volume":"199","author":"DV Chandrashekar","year":"2024","unstructured":"Chandrashekar DV, Roules GC, Jagadeesan N, Panchal UR, Oyegbesan A, Imiruaye OE, Zhang H, Garcia J, Kaur K, Win S, et al. Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer\u2019s disease mice: potential role in chronic heavy alcohol feeding. Neurobiol Dis. 2024;199:106570.","journal-title":"Neurobiol Dis"},{"key":"849_CR38","doi-asserted-by":"publisher","first-page":"14328","DOI":"10.1021\/bi035038d","volume":"42","author":"SK Rangan","year":"2003","unstructured":"Rangan SK, Liu R, Brune D, Planque S, Paul S, Sierks MR. Degradation of beta-amyloid by proteolytic antibody light chains. Biochemistry. 2003;42:14328\u201334.","journal-title":"Biochemistry"},{"key":"849_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Kaneko N, Villemagne VL, Kato T, Doecke J, Dor\u00e9 V, Fowler C, Li Q-X, Martins R, Rowe C, et al. High performance plasma amyloid-\u03b2 biomarkers for Alzheimer\u2019s disease. Nature. 2018;554:249\u201354.","journal-title":"Nature"},{"key":"849_CR40","doi-asserted-by":"publisher","first-page":"263310552211230","DOI":"10.1177\/26331055221123072","volume":"17","author":"N Gamez","year":"2022","unstructured":"Gamez N, Morales R. The role of Circulating A\u03b2 seeds in the progression of cerebral amyloidosis. Neurosci Insights. 2022;17:26331055221123072.","journal-title":"Neurosci Insights"},{"key":"849_CR41","doi-asserted-by":"publisher","first-page":"5690","DOI":"10.1038\/s41380-021-01150-w","volume":"26","author":"R Morales","year":"2021","unstructured":"Morales R, Bravo-Alegria J, Moreno-Gonzalez I, Duran-Aniotz C, Gamez N, Edwards Iii G, Soto C. Transmission of cerebral amyloid pathology by peripheral administration of misfolded A\u03b2 aggregates. Mol Psychiatry. 2021;26:5690\u2013701.","journal-title":"Mol Psychiatry"},{"key":"849_CR42","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.3233\/JAD-151087","volume":"54","author":"LD Estrada","year":"2016","unstructured":"Estrada LD, Chamorro D, Ya\u00f1ez MJ, Gonzalez M, Leal N, von Bernhardi R, Dulcey AE, Marugan J, Ferrer M, Soto C, et al. Reduction of blood Amyloid-\u03b2 oligomers in Alzheimer\u2019s disease Transgenic mice by c-Abl kinase Inhibition. J Alzheimer\u2019s Disease: JAD. 2016;54:1193\u2013205.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2013.05.002","volume":"33","author":"MK Weintraub","year":"2013","unstructured":"Weintraub MK, Bisson CM, Nouri JN, Vinson BT, Eimerbrink MJ, Kranjac D, Boehm GW, Chumley MJ. Imatinib methanesulfonate reduces hippocampal amyloid-\u03b2 and restores cognitive function following repeated endotoxin exposure. Brain Behav Immun. 2013;33:24\u20138.","journal-title":"Brain Behav Immun"},{"key":"849_CR44","doi-asserted-by":"publisher","first-page":"45897","DOI":"10.1074\/jbc.M407668200","volume":"279","author":"J Ghiso","year":"2004","unstructured":"Ghiso J, Shayo M, Calero M, Ng D, Tomidokoro Y, Gandy S, Rostagno A, Frangione B. Systemic catabolism of Alzheimer\u2019s Abeta40 and Abeta42. J Biol Chem. 2004;279:45897\u2013908.","journal-title":"J Biol Chem"},{"key":"849_CR45","doi-asserted-by":"publisher","first-page":"105079","DOI":"10.1016\/j.ebiom.2024.105079","volume":"102","author":"X Peng","year":"2024","unstructured":"Peng X, Zhang X, Xu Z, Li L, Mo X, Peng Z, Shan Z, Yan H, Xu J, Liu L. Peripheral amyloid-\u03b2 clearance mediates cognitive impairment in non-alcoholic fatty liver disease. EBioMedicine. 2024;102:105079.","journal-title":"EBioMedicine"},{"key":"849_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00401-023-02559-z","volume":"145","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, He CY, Tian DY, Chen SH, Ren JR, Sun HL, Xu MY, Tan CR, Fan DY, Jian JM, et al. Physiological \u03b2-amyloid clearance by the liver and its therapeutic potential for Alzheimer\u2019s disease. Acta Neuropathol. 2023;145:717\u201331.","journal-title":"Acta Neuropathol"},{"key":"849_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12974-023-03003-5","volume":"21","author":"M Shi","year":"2024","unstructured":"Shi M, Chu F, Zhu F, Zhu J. Peripheral blood amyloid-\u03b2 involved in the pathogenesis of Alzheimer\u2019s disease via impacting on peripheral innate immune cells. J Neuroinflamm. 2024;21:5.","journal-title":"J Neuroinflamm"},{"key":"849_CR48","doi-asserted-by":"publisher","first-page":"e0203659","DOI":"10.1371\/journal.pone.0203659","volume":"13","author":"CL Maarouf","year":"2018","unstructured":"Maarouf CL, Walker JE, Sue LI, Dugger BN, Beach TG, Serrano GE. Impaired hepatic amyloid-beta degradation in Alzheimer\u2019s disease. PLoS ONE. 2018;13:e0203659.","journal-title":"PLoS ONE"},{"key":"849_CR49","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1007\/s12035-016-9826-1","volume":"54","author":"YR Wang","year":"2017","unstructured":"Wang YR, Wang QH, Zhang T, Liu YH, Yao XQ, Zeng F, Li J, Zhou FY, Wang L, Yan JC, et al. Associations between hepatic functions and plasma Amyloid-Beta Levels-Implications for the capacity of liver in peripheral Amyloid-Beta clearance. Mol Neurobiol. 2017;54:2338\u201344.","journal-title":"Mol Neurobiol"},{"key":"849_CR50","doi-asserted-by":"publisher","first-page":"e3001358","DOI":"10.1371\/journal.pbio.3001358","volume":"19","author":"V Lam","year":"2021","unstructured":"Lam V, Takechi R, Hackett MJ, Francis R, Bynevelt M, Celliers LM, Nesbit M, Mamsa S, Arfuso F, Das S, et al. Synthesis of human amyloid restricted to liver results in an alzheimer disease-like neurodegenerative phenotype. PLoS Biol. 2021;19:e3001358.","journal-title":"PLoS Biol"},{"key":"849_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JAD-220599","volume":"92","author":"DJ Panyard","year":"2023","unstructured":"Panyard DJ, Deming YK, Darst BF, Van Hulle CA, Zetterberg H, Blennow K, Kollmorgen G, Suridjan I, Carlsson CM, Johnson SC, et al. Liver-Specific polygenic risk score is associated with Alzheimer\u2019s disease diagnosis. J Alzheimer\u2019s Disease: JAD. 2023;92:395\u2013409.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR52","doi-asserted-by":"publisher","first-page":"e13533","DOI":"10.1111\/acel.13533","volume":"21","author":"ZY Yu","year":"2022","unstructured":"Yu ZY, Chen DW, Tan CR, Zeng GH, He CY, Wang J, Bu XL, Wang YJ. Physiological clearance of A\u03b2 by spleen and splenectomy aggravates Alzheimer-type pathogenesis. Aging Cell. 2022;21:e13533.","journal-title":"Aging Cell"},{"key":"849_CR53","doi-asserted-by":"publisher","first-page":"6074","DOI":"10.1038\/s41380-021-01073-6","volume":"26","author":"DY Tian","year":"2021","unstructured":"Tian DY, Cheng Y, Zhuang ZQ, He CY, Pan QG, Tang MZ, Hu XL, Shen YY, Wang YR, Chen SH, et al. Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer\u2019s disease. Mol Psychiatry. 2021;26:6074\u201382.","journal-title":"Mol Psychiatry"},{"key":"849_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM. \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegeneration. 2019;14:23.","journal-title":"Mol Neurodegeneration"},{"key":"849_CR55","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00401-018-1891-2","volume":"136","author":"J Wang","year":"2018","unstructured":"Wang J, Jin WS, Bu XL, Zeng F, Huang ZL, Li WW, Shen LL, Zhuang ZQ, Fang Y, Sun BL, et al. Physiological clearance of Tau in the periphery and its therapeutic potential for Tauopathies. Acta Neuropathol. 2018;136:525\u201336.","journal-title":"Acta Neuropathol"},{"key":"849_CR56","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41582-018-0071-2","volume":"14","author":"MJ de Leon","year":"2018","unstructured":"de Leon MJ, Blennow K. Therapeutic potential for peripheral clearance of misfolded brain proteins. Nat Reviews Neurol. 2018;14:637\u20138.","journal-title":"Nat Reviews Neurol"},{"key":"849_CR57","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40478-021-01136-3","volume":"9","author":"JF Reyes","year":"2021","unstructured":"Reyes JF, Ekmark-L\u00e9wen S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, Nilsson P, Nilsson KPR, Alafuzoff I, Ingelsson M, Hallbeck M. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease. Acta Neuropathol Commun. 2021;9:46.","journal-title":"Acta Neuropathol Commun"},{"key":"849_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.peptides.2014.09.018","volume":"62","author":"YT Sui","year":"2014","unstructured":"Sui YT, Bullock KM, Erickson MA, Zhang J, Banks WA. Alpha synuclein is transported into and out of the brain by the blood-brain barrier. Peptides. 2014;62:197\u2013202.","journal-title":"Peptides"},{"key":"849_CR59","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, Lee JH, Kim WR, Kook M, Foss CA, et al. Transneuronal propagation of pathologic \u03b1-Synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627\u2013e641627.","journal-title":"Neuron"},{"key":"849_CR60","doi-asserted-by":"publisher","first-page":"e0306839","DOI":"10.1371\/journal.pone.0306839","volume":"19","author":"YL Zhang","year":"2024","unstructured":"Zhang YL, Jia SY, Yang B, Miao J, Su C, Cui ZG, Yang LM, Guo JH. Non-linear association of liver enzymes with cognitive performance in the elderly: A cross-sectional study. PLoS ONE. 2024;19:e0306839.","journal-title":"PLoS ONE"},{"key":"849_CR61","first-page":"19","volume":"35","author":"R Manafikhi","year":"2021","unstructured":"Manafikhi R, Haik MB, Lahdo R, AlQuobaili F. Plasma amyloid \u0392 levels in Alzheimer\u2019s disease and cognitively normal controls in Syrian population. Med J Islamic Repub Iran. 2021;35:19.","journal-title":"Med J Islamic Repub Iran"},{"key":"849_CR62","doi-asserted-by":"publisher","first-page":"e197978","DOI":"10.1001\/jamanetworkopen.2019.7978","volume":"2","author":"K Nho","year":"2019","unstructured":"Nho K, Kueider-Paisley A, Ahmad S, MahmoudianDehkordi S, Arnold M, Risacher SL, Louie G, Blach C, Baillie R, Han X, et al. Association of altered liver enzymes with alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open. 2019;2:e197978.","journal-title":"JAMA Netw Open"},{"key":"849_CR63","doi-asserted-by":"publisher","first-page":"1411466","DOI":"10.3389\/fnagi.2024.1411466","volume":"16","author":"SW Han","year":"2024","unstructured":"Han SW, Lee SH, Kim JH, Lee JJ, Park YH, Kim S, Nho K, Sohn JH. Association of liver function markers and Apolipoprotein E \u03954 with pathogenesis and cognitive decline in Alzheimer\u2019s disease. Front Aging Neurosci. 2024;16:1411466.","journal-title":"Front Aging Neurosci"},{"key":"849_CR64","doi-asserted-by":"publisher","first-page":"780174","DOI":"10.3389\/fmed.2022.780174","volume":"9","author":"W Li","year":"2022","unstructured":"Li W, Yue L, Sun L, Xiao S. An increased aspartate to Alanine aminotransferase ratio is associated with a higher risk of cognitive impairment. Front Med. 2022;9:780174.","journal-title":"Front Med"},{"key":"849_CR65","doi-asserted-by":"publisher","first-page":"1012219","DOI":"10.3389\/fnagi.2022.1012219","volume":"14","author":"K Wu","year":"2022","unstructured":"Wu K, Xu C, Qiu G, Guo Q, Chen C, Liu W, Liu J, Liu K, Zhu F. Association of lower liver function with cognitive impairment in the Shenzhen ageing-related disorder cohort in China. Front Aging Neurosci. 2022;14:1012219.","journal-title":"Front Aging Neurosci"},{"key":"849_CR66","doi-asserted-by":"crossref","unstructured":"Lo EKK, Felicianna, Xu JH, Zhan Q, Zeng Z, El-Nezami H. The emerging role of Branched-Chain amino acids in liver diseases. Biomedicines 2022;10(6):1444.","DOI":"10.3390\/biomedicines10061444"},{"key":"849_CR67","doi-asserted-by":"crossref","unstructured":"Claeys W, Van Hoecke L, Lefere S, Geerts A, Verhelst X, Van Vlierberghe H, Degroote H, Devisscher L, Vandenbroucke RE, Van Steenkiste C. The neurogliovascular unit in hepatic encephalopathy. JHEP Reports: Innov Hepatol. 2021;3:100352.","DOI":"10.1016\/j.jhepr.2021.100352"},{"key":"849_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neuroscience.2012.12.035","volume":"233","author":"Y Izumi","year":"2013","unstructured":"Izumi Y, Svrakic N, O\u2019Dell K, Zorumski CF. Ammonia inhibits long-term potentiation via neurosteroid synthesis in hippocampal pyramidal neurons. Neuroscience. 2013;233:166\u201373.","journal-title":"Neuroscience"},{"key":"849_CR69","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3748\/wjg.v29.i19.2905","volume":"29","author":"G Marrone","year":"2023","unstructured":"Marrone G, Serra A, Miele L, Biolato M, Liguori A, Grieco A, Gasbarrini A. Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: evidence and uncertainties. World J Gastroenterol. 2023;29:2905\u201315.","journal-title":"World J Gastroenterol"},{"key":"849_CR70","doi-asserted-by":"crossref","unstructured":"Litus EA, Kazakov AS, Deryusheva EI, Nemashkalova EL, Shevelyova MP, Nazipova AA, Permyakova ME, Raznikova EV, Uversky VN, Permyakov SE. Serotonin promotes serum albumin interaction with the monomeric amyloid \u0392 peptide. Int J Mol Sci 2021;22(11):5896.","DOI":"10.3390\/ijms22115896"},{"key":"849_CR71","doi-asserted-by":"publisher","first-page":"629520","DOI":"10.3389\/fmolb.2020.629520","volume":"7","author":"H Xie","year":"2020","unstructured":"Xie H, Guo C. Albumin alters the conformational ensemble of amyloid-\u03b2 by promiscuous interactions: implications for amyloid Inhibition. Front Mol Biosci. 2020;7:629520.","journal-title":"Front Mol Biosci"},{"key":"849_CR72","doi-asserted-by":"publisher","first-page":"140367","DOI":"10.1016\/j.ijbiomac.2025.140367","volume":"301","author":"D Cora","year":"2025","unstructured":"Cora D, Al-Soufi W, Novo M. Amyloid capture and aggregation Inhibition by human serum albumin. Int J Biol Macromol. 2025;301:140367.","journal-title":"Int J Biol Macromol"},{"key":"849_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.livres.2022.05.002","volume":"6","author":"A Bashir","year":"2022","unstructured":"Bashir A, Duseja A, De A, Mehta M, Tiwari P. Non-alcoholic fatty liver disease development: A multifactorial pathogenic phenomena. Liver Res. 2022;6:72\u201383.","journal-title":"Liver Res"},{"key":"849_CR74","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-020-03003-w","volume":"11","author":"P Rada","year":"2020","unstructured":"Rada P, Gonz\u00e1lez-Rodr\u00edguez \u00c1, Garc\u00eda-Monz\u00f3n C, Valverde \u00c1M. Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver? Cell Death Dis. 2020;11:802.","journal-title":"Cell Death Dis"},{"key":"849_CR75","doi-asserted-by":"crossref","unstructured":"Syed-Abdul MM. Lipid metabolism in Metabolic-Associated steatotic liver disease (MASLD). Metabolites 2023;14(1):12.","DOI":"10.3390\/metabo14010012"},{"key":"849_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40035-023-00364-y","volume":"12","author":"L Xu","year":"2023","unstructured":"Xu L, Liu R, Qin Y, Wang T. Brain metabolism in Alzheimer\u2019s disease: biological mechanisms of exercise. Translational Neurodegeneration. 2023;12:33.","journal-title":"Translational Neurodegeneration"},{"key":"849_CR77","doi-asserted-by":"publisher","first-page":"560375","DOI":"10.3389\/fendo.2020.560375","volume":"11","author":"J Berlanga-Acosta","year":"2020","unstructured":"Berlanga-Acosta J, Guill\u00e9n-Nieto G, Rodr\u00edguez-Rodr\u00edguez N, Bringas-Vega ML, Garc\u00eda-Del-Barco-Herrera D, Berlanga-Saez JO, Garc\u00eda-Ojalvo A, Vald\u00e9s-Sosa MJ. Vald\u00e9s-Sosa PA: insulin resistance at the crossroad of alzheimer disease pathology: A review. Front Endocrinol. 2020;11:560375.","journal-title":"Front Endocrinol"},{"key":"849_CR78","doi-asserted-by":"publisher","first-page":"687157","DOI":"10.3389\/fnins.2021.687157","volume":"15","author":"Z Wei","year":"2021","unstructured":"Wei Z, Koya J, Reznik SE. Insulin resistance exacerbates alzheimer disease via multiple mechanisms. Front NeuroSci. 2021;15:687157.","journal-title":"Front NeuroSci"},{"key":"849_CR79","doi-asserted-by":"crossref","unstructured":"Huang H, Wang J, Xu L, Miao M, Xu C. Association between High-Density Lipoprotein Cholesterol to Apolipoprotein A-I Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. International journal of endocrinology 2021, 2021:6676526.","DOI":"10.1155\/2021\/6676526"},{"key":"849_CR80","doi-asserted-by":"crossref","unstructured":"Marsillach J, Adorni MP, Zimetti F, Papotti B, Zuliani G, Cervellati C. HDL Proteome and Alzheimer\u2019s Disease: Evidence of a Link. Antioxid (Basel Switzerland) 2020;9(12):1224.","DOI":"10.3390\/antiox9121224"},{"key":"849_CR81","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Therapy. 2023;8:267.","journal-title":"Signal Transduct Target Therapy"},{"key":"849_CR82","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2016.10.037","volume":"255","author":"KL Rasmussen","year":"2016","unstructured":"Rasmussen KL. Plasma levels of Apolipoprotein E, \u2009apoe\u2009genotype and risk of dementia and ischemic heart disease: A review. Atherosclerosis. 2016;255:145\u201355.","journal-title":"Atherosclerosis"},{"key":"849_CR83","doi-asserted-by":"publisher","first-page":"e70202","DOI":"10.1111\/cns.70202","volume":"31","author":"B Zhao","year":"2025","unstructured":"Zhao B, Zang P, Quan M, Wang Q, Guo D, Jia J, Wang W. The effect of APOE \u03954 on Alzheimer\u2019s disease fluid biomarkers: A Cross-Sectional study based on the COAST. CNS Neurosci Ther. 2025;31:e70202.","journal-title":"CNS Neurosci Ther"},{"key":"849_CR84","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.jlr.2024.100498","volume":"65","author":"FC Almeida","year":"2024","unstructured":"Almeida FC, Patra K, Giannisis A, Niesnerova A, Nandakumar R, Ellis E, Oliveira TG, Nielsen HM. APOE genotype dictates lipidomic signatures in primary human hepatocytes. J Lipid Res. 2024;65:100498.","journal-title":"J Lipid Res"},{"key":"849_CR85","first-page":"e60721","volume":"16","author":"HK Krishnamurthy","year":"2024","unstructured":"Krishnamurthy HK, Rajavelu I, Reddy S, Pereira M, Jayaraman V, Krishna K, Song Q, Wang T, Bei K, Rajasekaran JJ. Association of Apolipoprotein E (APOE) polymorphisms with serological lipid and inflammatory markers. Cureus. 2024;16:e60721.","journal-title":"Cureus"},{"key":"849_CR86","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11883-012-0307-3","volume":"15","author":"C Reitz","year":"2013","unstructured":"Reitz C. Dyslipidemia and the risk of Alzheimer\u2019s disease. Curr Atheroscler Rep. 2013;15:307.","journal-title":"Curr Atheroscler Rep"},{"key":"849_CR87","doi-asserted-by":"crossref","unstructured":"Getz GS, Reardon CA. Apoprotein E and reverse cholesterol transport. Int J Mol Sci 2018;19(11):3479.","DOI":"10.3390\/ijms19113479"},{"key":"849_CR88","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","volume":"25","author":"CC Liu","year":"2022","unstructured":"Liu CC, Zhao J, Fu Y, Inoue Y, Ren Y, Chen Y, Doss SV, Shue F, Jeevaratnam S, Bastea L, et al. Peripheral apoE4 enhances Alzheimer\u2019s pathology and impairs cognition by compromising cerebrovascular function. Nat Neurosci. 2022;25:1020\u201333.","journal-title":"Nat Neurosci"},{"key":"849_CR89","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1038\/s41380-022-01548-0","volume":"27","author":"A Giannisis","year":"2022","unstructured":"Giannisis A, Patra K, Edlund AK, Nieto LA, Benedicto-Gras J, Moussaud S, de la Rosa A, Twohig D, Bengtsson T, Fu Y, et al. Brain integrity is altered by hepatic APOE \u03954 in humanized-liver mice. Mol Psychiatry. 2022;27:3533\u201343.","journal-title":"Mol Psychiatry"},{"key":"849_CR90","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, Menon M, He L, Abdurrob F, Jiang X, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570:332\u20137.","journal-title":"Nature"},{"key":"849_CR91","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-022-00569-1","volume":"17","author":"LR Golden","year":"2022","unstructured":"Golden LR, Johnson LA. Liver-ing in your head rent free: peripheral ApoE4 drives CNS pathology. Mol Neurodegener. 2022;17:65.","journal-title":"Mol Neurodegener"},{"key":"849_CR92","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s12975-023-01196-8","volume":"15","author":"PT Do","year":"2024","unstructured":"Do PT, Chuang DM, Wu CC, Huang CZ, Chen YH, Kang SJ, Chiang YH, Hu CJ, Chen KY. Mesenchymal stem cells overexpressing FGF21 preserve Blood-Brain barrier integrity in experimental ischemic stroke. Translational Stroke Res. 2024;15:1165\u201375.","journal-title":"Translational Stroke Res"},{"key":"849_CR93","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.redox.2019.101133","volume":"22","author":"S Chen","year":"2019","unstructured":"Chen S, Chen ST, Sun Y, Xu Z, Wang Y, Yao SY, Yao WB, Gao XD. Fibroblast growth factor 21 ameliorates neurodegeneration in rat and cellular models of Alzheimer\u2019s disease. Redox Biol. 2019;22:101133.","journal-title":"Redox Biol"},{"key":"849_CR94","doi-asserted-by":"publisher","first-page":"110439","DOI":"10.1016\/j.biopha.2020.110439","volume":"129","author":"K Kang","year":"2020","unstructured":"Kang K, Xu P, Wang M, Chunyu J, Sun X, Ren G, Xiao W, Li D. FGF21 attenuates neurodegeneration through modulating neuroinflammation and oxidant-stress. Biomed Pharmacother. 2020;129:110439.","journal-title":"Biomed Pharmacother"},{"key":"849_CR95","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","volume":"582","author":"Y Izumiya","year":"2008","unstructured":"Izumiya Y, Bina HA, Ouchi N, Akasaki Y, Kharitonenkov A, Walsh K. FGF21 is an Akt-regulated myokine. FEBS Lett. 2008;582:3805\u201310.","journal-title":"FEBS Lett"},{"key":"849_CR96","doi-asserted-by":"publisher","first-page":"101798","DOI":"10.1016\/j.molmet.2023.101798","volume":"77","author":"MF Ho","year":"2023","unstructured":"Ho MF, Zhang C, Moon I, Biernacka J, Coombes B, Ngo Q, Skillon C, Skime M, Oesterle T, Croarkin PE, et al. Epigenetic regulation of GABA catabolism in iPSC-derived neurons: the molecular links between FGF21 and histone methylation. Mol Metabolism. 2023;77:101798.","journal-title":"Mol Metabolism"},{"key":"849_CR97","doi-asserted-by":"crossref","unstructured":"Epperlein S, Gebhardt C, Rohde K, Chakaroun R, Patt M, Schamarek I, Kralisch S, Heiker JT, Scholz M, Stumvoll M et al. The effect of FGF21 and its genetic variants on food and drug cravings, adipokines and metabolic traits. Biomedicines 2021;9(4):345.","DOI":"10.3390\/biomedicines9040345"},{"key":"849_CR98","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12974-020-01921-2","volume":"17","author":"D Wang","year":"2020","unstructured":"Wang D, Liu F, Zhu L, Lin P, Han F, Wang X, Tan X, Lin L, Xiong Y. FGF21 alleviates neuroinflammation following ischemic stroke by modulating the Temporal and Spatial dynamics of microglia\/macrophages. J Neuroinflamm. 2020;17:257.","journal-title":"J Neuroinflamm"},{"key":"849_CR99","doi-asserted-by":"publisher","first-page":"e2400125","DOI":"10.1002\/adhm.202400125","volume":"13","author":"HC Wang","year":"2024","unstructured":"Wang HC, Yang W, Xu L, Han YH, Lin Y, Lu CT, Kim K, Zhao YZ, Yu XC. BV2 Membrane-Coated PEGylated-Liposomes delivered hFGF21 to cortical and hippocampal microglia for Alzheimer\u2019s disease therapy. Adv Healthc Mater. 2024;13:e2400125.","journal-title":"Adv Healthc Mater"},{"key":"849_CR100","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3233\/JAD-200837","volume":"80","author":"C R\u00fchlmann","year":"2021","unstructured":"R\u00fchlmann C, Dannehl D, Brodtr\u00fcck M, Adams AC, Stenzel J, Lindner T, Krause BJ, Vollmar B, Kuhla A. Neuroprotective effects of the FGF21 analogue LY2405319. J Alzheimer\u2019s Disease: JAD. 2021;80:357\u201369.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR101","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1007\/s12035-022-02741-6","volume":"59","author":"V Kakoty","year":"2022","unstructured":"Kakoty V, C SK, Yang CH, Kumari S, Dubey SK, Taliyan R. Neuroprotective effect of Lentivirus-Mediated FGF21 gene delivery in experimental Alzheimer\u2019s disease is augmented when concerted with Rapamycin. Mol Neurobiol. 2022;59:2659\u201377.","journal-title":"Mol Neurobiol"},{"key":"849_CR102","doi-asserted-by":"publisher","first-page":"108335","DOI":"10.1016\/j.neuropharm.2020.108335","volume":"181","author":"Y Chen","year":"2020","unstructured":"Chen Y, Shen J, Qi G, Zha Q, Zhang C, Yao W, Gao X, Chen S. Potential therapeutic role of fibroblast growth factor 21 in neurodegeneration: evidence for ameliorating parkinsonism via silent information regulator 2 homolog 1 and implication for gene therapy. Neuropharmacology. 2020;181:108335.","journal-title":"Neuropharmacology"},{"key":"849_CR103","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s12640-019-00151-6","volume":"37","author":"X Fang","year":"2020","unstructured":"Fang X, Ma J, Mu D, Li B, Lian B, Sun C. FGF21 protects dopaminergic neurons in Parkinson\u2019s disease models via repression of neuroinflammation. Neurotox Res. 2020;37:616\u201327.","journal-title":"Neurotox Res"},{"key":"849_CR104","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1111\/cns.14302","volume":"29","author":"C Yang","year":"2023","unstructured":"Yang C, Wang W, Deng P, Wang X, Zhu L, Zhao L, Li C, Gao H. Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson\u2019s disease mouse model via modulating gut microbiota and metabolic homeostasis. CNS Neurosci Ther. 2023;29:3815\u201328.","journal-title":"CNS Neurosci Ther"},{"key":"849_CR105","doi-asserted-by":"crossref","unstructured":"Genchi G, Lauria G, Catalano A, Sinicropi MS, Carocci A. Biological activity of selenium and its impact on human health. Int J Mol Sci 2023;24(3):2633.","DOI":"10.3390\/ijms24032633"},{"key":"849_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.19-31","volume":"66","author":"Y Saito","year":"2020","unstructured":"Saito Y. Selenoprotein P as an in vivo redox regulator: disorders related to its deficiency and excess. J Clin Biochem Nutr. 2020;66:1\u20137.","journal-title":"J Clin Biochem Nutr"},{"key":"849_CR107","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2202-13-79","volume":"13","author":"SL Mehta","year":"2012","unstructured":"Mehta SL, Kumari S, Mendelev N, Li PA. Selenium preserves mitochondrial function, stimulates mitochondrial biogenesis, and reduces infarct volume after focal cerebral ischemia. BMC Neurosci. 2012;13:79.","journal-title":"BMC Neurosci"},{"key":"849_CR108","doi-asserted-by":"crossref","unstructured":"Saito Y. Selenium transport mechanism via Selenoprotein P\u2014Its physiological role and related diseases. Front Nutr 2021;8:685517.","DOI":"10.3389\/fnut.2021.685517"},{"key":"849_CR109","doi-asserted-by":"publisher","first-page":"123740","DOI":"10.1016\/j.ijbiomac.2023.123740","volume":"234","author":"X Liang","year":"2023","unstructured":"Liang X, Xue Z, Zheng Y, Li S, Zhou L, Cao L, Zou Y. Selenium supplementation enhanced the expression of selenoproteins in hippocampus and played a neuroprotective role in LPS-induced neuroinflammation. Int J Biol Macromol. 2023;234:123740.","journal-title":"Int J Biol Macromol"},{"key":"849_CR110","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2174\/1570159X18666200106152631","volume":"18","author":"M Naz\u0131ro\u011flu","year":"2020","unstructured":"Naz\u0131ro\u011flu M, \u00d6z A, Y\u0131ld\u0131zhan K. Selenium and neurological diseases: focus on peripheral pain and TRP channels. Curr Neuropharmacol. 2020;18:501\u201317.","journal-title":"Curr Neuropharmacol"},{"key":"849_CR111","doi-asserted-by":"publisher","first-page":"646518","DOI":"10.3389\/fnins.2021.646518","volume":"15","author":"ZH Zhang","year":"2021","unstructured":"Zhang ZH, Song GL. Roles of selenoproteins in brain function and the potential mechanism of selenium in Alzheimer\u2019s disease. Front NeuroSci. 2021;15:646518.","journal-title":"Front NeuroSci"},{"key":"849_CR112","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1007\/s00018-019-03287-y","volume":"77","author":"Y Jin","year":"2020","unstructured":"Jin Y, Chung YW, Jung MK, Lee JH, Ko KY, Jang JK, Ham M, Kang H, Pack CG, Mihara H, Kim IY. Apolipoprotein E-mediated regulation of Selenoprotein P transportation via exosomes. Cell Mol Life Sci. 2020;77:2367\u201386.","journal-title":"Cell Mol Life Sci"},{"key":"849_CR113","doi-asserted-by":"publisher","first-page":"683154","DOI":"10.3389\/fnut.2021.683154","volume":"8","author":"ACP Kiyohara","year":"2021","unstructured":"Kiyohara ACP, Torres DJ, Hagiwara A, Pak J, Rueli R, Shuttleworth CWR, Bellinger FP. Selenoprotein P regulates synaptic zinc and reduces Tau phosphorylation. Front Nutr. 2021;8:683154.","journal-title":"Front Nutr"},{"key":"849_CR114","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1096\/fj.14-252874","volume":"28","author":"RF Burk","year":"2014","unstructured":"Burk RF, Hill KE, Motley AK, Winfrey VP, Kurokawa S, Mitchell SL, Zhang W. Selenoprotein P and Apolipoprotein E receptor-2 interact at the blood-brain barrier and also within the brain to maintain an essential selenium pool that protects against neurodegeneration. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2014;28:3579\u201388.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"849_CR115","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1021\/ic4028282","volume":"53","author":"X Du","year":"2014","unstructured":"Du X, Wang Z, Zheng Y, Li H, Ni J, Liu Q. Inhibitory effect of Selenoprotein P on Cu(+)\/Cu(2+)-induced A\u03b242 aggregation and toxicity. Inorg Chem. 2014;53:1672\u20138.","journal-title":"Inorg Chem"},{"key":"849_CR116","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1039\/c3mt20282h","volume":"5","author":"X Du","year":"2013","unstructured":"Du X, Li H, Wang Z, Qiu S, Liu Q, Ni J. Selenoprotein P and Selenoprotein M block Zn2+ -mediated A\u03b242 aggregation and toxicity. Metallomics: Integr Biometal Sci. 2013;5:861\u201370.","journal-title":"Metallomics: Integr Biometal Sci"},{"key":"849_CR117","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.freeradbiomed.2018.02.030","volume":"127","author":"N Solovyev","year":"2018","unstructured":"Solovyev N, Drobyshev E, Bj\u00f8rklund G, Dubrovskii Y, Lysiuk R, Rayman MP. Selenium, Selenoprotein P, and Alzheimer\u2019s disease: is there a link? Free Radic Biol Med. 2018;127:124\u201333.","journal-title":"Free Radic Biol Med"},{"key":"849_CR118","doi-asserted-by":"crossref","unstructured":"Urbano T, Vinceti M, Mandrioli J, Chiari A, Filippini T, Bedin R, Tondelli M, Simonini C, Zamboni G, Shimizu M, Saito Y. Selenoprotein P Concentrations in the Cerebrospinal Fluid and Serum of Individuals Affected by Amyotrophic Lateral Sclerosis, Mild Cognitive Impairment and Alzheimer\u2019s Dementia. Int J Mol Sci 2022;23(17):9865.","DOI":"10.3390\/ijms23179865"},{"key":"849_CR119","doi-asserted-by":"publisher","first-page":"8792","DOI":"10.1038\/s41598-023-36084-6","volume":"13","author":"M Vinceti","year":"2023","unstructured":"Vinceti M, Urbano T, Chiari A, Filippini T, Wise LA, Tondelli M, Michalke B, Shimizu M, Saito Y. Selenoprotein P concentrations and risk of progression from mild cognitive impairment to dementia. Sci Rep. 2023;13:8792.","journal-title":"Sci Rep"},{"key":"849_CR120","doi-asserted-by":"publisher","first-page":"126412","DOI":"10.1016\/j.jtemb.2019.126412","volume":"57","author":"F Maass","year":"2020","unstructured":"Maass F, Michalke B, Willkommen D, Schulte C, T\u00f6nges L, Boerger M, Zerr I, B\u00e4hr M, Lingor P. Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson\u2019s disease. J Trace Elem Med Biology: Organ Soc Minerals Trace Elem (GMS). 2020;57:126412.","journal-title":"J Trace Elem Med Biology: Organ Soc Minerals Trace Elem (GMS)"},{"key":"849_CR121","doi-asserted-by":"crossref","unstructured":"Du\u021b\u0103 C, Muscurel C, Dogaru CB, Stoian I. Selenoproteins: Zoom-In to their Metal-Binding properties in neurodegenerative diseases. Int J Mol Sci 2025;26(3):1305.","DOI":"10.3390\/ijms26031305"},{"key":"849_CR122","doi-asserted-by":"publisher","first-page":"945287","DOI":"10.3389\/fcell.2022.945287","volume":"10","author":"E Chekol Abebe","year":"2022","unstructured":"Chekol Abebe E, Tilahun Muche Z, Behaile TMA, Mengie Ayele T, Mekonnen Agidew M, Teshome Azezew M, Abebe Zewde E, Asmamaw Dejenie T, Asmamaw Mengstie M. The structure, biosynthesis, and biological roles of fetuin-A: A review. Front Cell Dev Biology. 2022;10:945287.","journal-title":"Front Cell Dev Biology"},{"key":"849_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2020.11.004","volume":"88","author":"MA Icer","year":"2021","unstructured":"Icer MA, Y\u0131ld\u0131ran H. Effects of fetuin-A with diverse functions and multiple mechanisms on human health. Clin Biochem. 2021;88:1\u201310.","journal-title":"Clin Biochem"},{"key":"849_CR124","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/fcp.12870","volume":"37","author":"V Sidheeque Hassan","year":"2023","unstructured":"Sidheeque Hassan V, Hanifa M, Navik U, Bali A. Exogenous fetuin-A protects against sepsis-induced myocardial injury by inhibiting oxidative stress and inflammation in mice. Fundam Clin Pharmacol. 2023;37:607\u201317.","journal-title":"Fundam Clin Pharmacol"},{"key":"849_CR125","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/jcbfm.2009.247","volume":"30","author":"H Wang","year":"2010","unstructured":"Wang H, Li W, Zhu S, Li J, D\u2019Amore J, Ward MF, Yang H, Wu R, Jahnen-Dechent W, Tracey KJ, et al. Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats. J Cereb Blood Flow Metabolism: Official J Int Soc Cereb Blood Flow Metabolism. 2010;30:493\u2013504.","journal-title":"J Cereb Blood Flow Metabolism: Official J Int Soc Cereb Blood Flow Metabolism"},{"key":"849_CR126","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2174\/156652412800620039","volume":"12","author":"H Wang","year":"2012","unstructured":"Wang H, Sama AE. Anti-inflammatory role of fetuin-A in injury and infection. Curr Mol Med. 2012;12:625\u201333.","journal-title":"Curr Mol Med"},{"key":"849_CR127","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12974-022-02633-5","volume":"19","author":"P Zhao","year":"2022","unstructured":"Zhao P, Wei Y, Sun G, Xu L, Wang T, Tian Y, Chao H, Tu Y, Ji J. Fetuin-A alleviates neuroinflammation against traumatic brain injury-induced microglial necroptosis by regulating Nrf-2\/HO-1 pathway. J Neuroinflamm. 2022;19:269.","journal-title":"J Neuroinflamm"},{"key":"849_CR128","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00406-019-01090-1","volume":"270","author":"G Fanelli","year":"2020","unstructured":"Fanelli G, Benedetti F, Wang SM, Lee SJ, Jun TY, Masand PS, Patkar AA, Han C, Serretti A, Pae CU, Fabbri C. Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly. Eur Arch Psychiatry Clin NeuroSci. 2020;270:901\u201310.","journal-title":"Eur Arch Psychiatry Clin NeuroSci"},{"key":"849_CR129","doi-asserted-by":"publisher","first-page":"308","DOI":"10.5483\/BMBRep.2022-0208","volume":"56","author":"S Yoon","year":"2023","unstructured":"Yoon S, Boonpraman N, Kim CY, Moon JS, Yi SS. Reduction of fetuin-A levels contributes to impairment of purkinje cells in cerebella of patients with Parkinson\u2019s disease. BMB Rep. 2023;56:308\u201313.","journal-title":"BMB Rep"},{"key":"849_CR130","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neulet.2009.10.053","volume":"468","author":"J Brettschneider","year":"2010","unstructured":"Brettschneider J, Lehmensiek V, Mogel H, Pfeifle M, Dorst J, Hendrich C, Ludolph AC, Tumani H. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS). Neurosci Lett. 2010;468:23\u20137.","journal-title":"Neurosci Lett"},{"key":"849_CR131","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1177\/1352458513477923","volume":"19","author":"VK Harris","year":"2013","unstructured":"Harris VK, Donelan N, Yan QJ, Clark K, Touray A, Rammal M, Sadiq SA. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis. Mult Scler. 2013;19:1462\u201372.","journal-title":"Mult Scler"},{"key":"849_CR132","doi-asserted-by":"publisher","first-page":"e1484","DOI":"10.1002\/ctm2.1484","volume":"13","author":"GF Watts","year":"2023","unstructured":"Watts GF, Chan DC. RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: findings and implications of a recent phase I study. Clin Translational Med. 2023;13:e1484.","journal-title":"Clin Translational Med"},{"key":"849_CR133","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.tcm.2023.01.008","volume":"34","author":"F Luo","year":"2024","unstructured":"Luo F, Das A, Khetarpal SA, Fang Z, Zelniker TA, Rosenson RS, Qamar A. ANGPTL3 Inhibition, dyslipidemia, and cardiovascular diseases. Trends Cardiovasc Med. 2024;34:215\u201322.","journal-title":"Trends Cardiovasc Med"},{"key":"849_CR134","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11883-022-01071-1","volume":"24","author":"F Mohamed","year":"2022","unstructured":"Mohamed F, Mansfield BS, Raal FJ. ANGPTL3 as a drug target in hyperlipidemia and atherosclerosis. Curr Atheroscler Rep. 2022;24:959\u201367.","journal-title":"Curr Atheroscler Rep"},{"key":"849_CR135","doi-asserted-by":"publisher","first-page":"e030476","DOI":"10.1161\/JAHA.123.030476","volume":"12","author":"JM Kraaijenhof","year":"2023","unstructured":"Kraaijenhof JM, Tromp TR, Nurmohamed NS, Reeskamp LF, Langenkamp M, Levels JHM, Boekholdt SM, Wareham NJ, Hoekstra M, Stroes ESG, et al. ANGPTL3 (Angiopoietin-Like 3) preferentially resides on High-Density lipoprotein in the human circulation, affecting its activity. J Am Heart Association. 2023;12:e030476.","journal-title":"J Am Heart Association"},{"key":"849_CR136","doi-asserted-by":"publisher","first-page":"1275932","DOI":"10.3389\/fnins.2023.1275932","volume":"17","author":"O Akyol","year":"2023","unstructured":"Akyol O, Akyol S, Chou MC, Chen S, Liu CK, Selek S, Soares JC, Chen CH. Lipids and lipoproteins May play a role in the neuropathology of Alzheimer\u2019s disease. Front NeuroSci. 2023;17:1275932.","journal-title":"Front NeuroSci"},{"key":"849_CR137","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.molmet.2017.06.014","volume":"6","author":"X Chi","year":"2017","unstructured":"Chi X, Britt EC, Shows HW, Hjelmaas AJ, Shetty SK, Cushing EM, Li W, Dou A, Zhang R, Davies BSJ. ANGPTL8 promotes the ability of ANGPTL3 to bind and inhibit lipoprotein lipase. Mol Metabolism. 2017;6:1137\u201349.","journal-title":"Mol Metabolism"},{"key":"849_CR138","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3389\/fimmu.2019.00950","volume":"10","author":"A Kamermans","year":"2019","unstructured":"Kamermans A, Rijnsburger M, Chakraborty A, van der Pol S, de Vries HE, van Horssen J. Reduced Angiopoietin-Like 4 expression in multiple sclerosis lesions facilitates lipid uptake by phagocytes via modulation of Lipoprotein-Lipase activity. Front Immunol. 2019;10:950.","journal-title":"Front Immunol"},{"key":"849_CR139","doi-asserted-by":"publisher","first-page":"101763","DOI":"10.1016\/j.arr.2022.101763","volume":"82","author":"Y-Y Liu","year":"2022","unstructured":"Liu Y-Y, Huo D, Zeng L-T, Fan G-Q, Shen T, Zhang T-M, Cai J-P, Cui J. Mesencephalic astrocyte-derived neurotrophic factor (MANF): structure, functions and therapeutic potential. Ageing Res Rev. 2022;82:101763.","journal-title":"Ageing Res Rev"},{"key":"849_CR140","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/j.csbj.2022.03.029","volume":"20","author":"KN Amarasinghe","year":"2022","unstructured":"Amarasinghe KN, Pelizzari-Raymundo D, Carlesso A, Chevet E, Eriksson LA, Jalil Mahdizadeh S. Sensor dimer disruption as a new mode of action to block the IRE1-mediated unfolded protein response. Comput Struct Biotechnol J. 2022;20:1584\u201392.","journal-title":"Comput Struct Biotechnol J"},{"key":"849_CR141","doi-asserted-by":"publisher","first-page":"1407576","DOI":"10.3389\/fphar.2024.1407576","volume":"15","author":"W Wen","year":"2024","unstructured":"Wen W, Li H, Lauffer M, Hu D, Zhang Z, Lin H, Wang Y, Leidinger M, Luo J. Sex-specific effects of alcohol on neurobehavioral performance and Endoplasmic reticulum stress: an analysis using neuron-specific MANF deficient mice. Front Pharmacol. 2024;15:1407576.","journal-title":"Front Pharmacol"},{"key":"849_CR142","doi-asserted-by":"publisher","first-page":"112066","DOI":"10.1016\/j.celrep.2023.112066","volume":"42","author":"V Kovaleva","year":"2023","unstructured":"Kovaleva V, Yu LY, Ivanova L, Shpironok O, Nam J, Eesmaa A, Kumpula EP, Sakson S, Toots U, Ustav M, et al. MANF regulates neuronal survival and UPR through its ER-located receptor IRE1\u03b1. Cell Rep. 2023;42:112066.","journal-title":"Cell Rep"},{"key":"849_CR143","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.tem.2022.01.001","volume":"33","author":"Q Tang","year":"2022","unstructured":"Tang Q, Li Y, He J. MANF: an emerging therapeutic target for metabolic diseases. Trends Endocrinol Metabolism. 2022;33:236\u201346.","journal-title":"Trends Endocrinol Metabolism"},{"key":"849_CR144","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00441-020-03263-0","volume":"382","author":"M J\u04d3ntti","year":"2020","unstructured":"J\u04d3ntti M, Harvey BK. Trophic activities of Endoplasmic reticulum proteins CDNF and MANF. Cell Tissue Res. 2020;382:83\u2013100.","journal-title":"Cell Tissue Res"},{"key":"849_CR145","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/j.celrep.2018.10.055","volume":"25","author":"KA Trychta","year":"2018","unstructured":"Trychta KA, B\u00e4ck S, Henderson MJ, Harvey BK. KDEL receptors are differentially regulated to maintain the ER proteome under calcium deficiency. Cell Rep. 2018;25:1829\u2013e18401826.","journal-title":"Cell Rep"},{"key":"849_CR146","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12974-019-1429-0","volume":"16","author":"S Xu","year":"2019","unstructured":"Xu S, Di Z, He Y, Wang R, Ma Y, Sun R, Li J, Wang T, Shen Y, Fang S, et al. Mesencephalic astrocyte-derived neurotrophic factor (MANF) protects against A\u03b2 toxicity via attenuating A\u03b2-induced Endoplasmic reticulum stress. J Neuroinflamm. 2019;16:35.","journal-title":"J Neuroinflamm"},{"key":"849_CR147","doi-asserted-by":"publisher","first-page":"111396","DOI":"10.1016\/j.intimp.2023.111396","volume":"127","author":"X Zhao","year":"2024","unstructured":"Zhao X, Wang Z, Wang J, Xu F, Zhang Y, Han D, Fang W. Mesencephalic astrocyte-derived neurotrophic factor (MANF) alleviates cerebral ischemia\/reperfusion injury in mice by regulating microglia polarization via A20\/NF-\u03baB pathway. Int Immunopharmacol. 2024;127:111396.","journal-title":"Int Immunopharmacol"},{"key":"849_CR148","doi-asserted-by":"publisher","first-page":"900725","DOI":"10.3389\/fncel.2022.900725","volume":"16","author":"H L\u00f5helaid","year":"2022","unstructured":"L\u00f5helaid H, Anttila JE, Liew HK, Tseng KY, Teppo J, Stratoulias V, Airavaara M. UPR responsive genes Manf and Xbp1 in stroke. Front Cell Neurosci. 2022;16:900725.","journal-title":"Front Cell Neurosci"},{"key":"849_CR149","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40478-023-01701-y","volume":"12","author":"JE Anttila","year":"2024","unstructured":"Anttila JE, Mattila OS, Liew H-K, M\u00e4tlik K, Mervaala E, Lindholm P, Lindahl M, Lindsberg PJ, Tseng K-Y, Airavaara M. MANF protein expression is upregulated in immune cells in the ischemic human brain and systemic Recombinant MANF delivery in rat ischemic stroke model demonstrates anti-inflammatory effects. Acta Neuropathol Commun. 2024;12:10.","journal-title":"Acta Neuropathol Commun"},{"key":"849_CR150","doi-asserted-by":"publisher","first-page":"640084","DOI":"10.3389\/fncel.2021.640084","volume":"15","author":"J Nam","year":"2021","unstructured":"Nam J, Koppinen TK, Voutilainen MH. MANF is neuroprotective in early stages of EAE, and elevated in spinal white matter by treatment with dexamethasone. Front Cell Neurosci. 2021;15:640084.","journal-title":"Front Cell Neurosci"},{"key":"849_CR151","doi-asserted-by":"crossref","unstructured":"Sivakumar B, Krishnan A. Mesencephalic Astrocyte-Derived neurotrophic factor (MANF): an emerging therapeutic target for neurodegenerative disorders. Cells 2023;12(7):1032.","DOI":"10.3390\/cells12071032"},{"key":"849_CR152","doi-asserted-by":"crossref","unstructured":"Bozic J, Kumric M, Ticinovic Kurir T, Males I, Borovac JA, Martinovic D, Vilovic M. Role of Adropin in cardiometabolic disorders: from pathophysiological mechanisms to therapeutic target. Biomedicines 2021;9(10):1407.","DOI":"10.3390\/biomedicines9101407"},{"key":"849_CR153","doi-asserted-by":"crossref","unstructured":"Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, et al. Identification of Adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metabol. 2008;8:468\u201381.","DOI":"10.1016\/j.cmet.2008.10.011"},{"key":"849_CR154","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.metop.2024.100299","volume":"23","author":"S Rooban","year":"2024","unstructured":"Rooban S, Arul Senghor KA, Vinodhini VM, Kumar JS. Adropin: A crucial regulator of cardiovascular health and metabolic balance. Metabolism Open. 2024;23:100299.","journal-title":"Metabolism Open"},{"key":"849_CR155","doi-asserted-by":"publisher","first-page":"C674","DOI":"10.1152\/ajpcell.00318.2022","volume":"324","author":"RE Gunraj","year":"2023","unstructured":"Gunraj RE, Yang C, Liu L, Larochelle J, Candelario-Jalil E. Protective roles of Adropin in neurological disease. Am J Physiol Cell Physiol. 2023;324:C674\u20138.","journal-title":"Am J Physiol Cell Physiol"},{"key":"849_CR156","doi-asserted-by":"publisher","first-page":"102197","DOI":"10.1016\/j.redox.2021.102197","volume":"48","author":"C Yang","year":"2021","unstructured":"Yang C, Lavayen BP, Liu L, Sanz BD, DeMars KM, Larochelle J, Pompilus M, Febo M, Sun YY, Kuo YM, et al. Neurovascular protection by Adropin in experimental ischemic stroke through an endothelial nitric oxide synthase-dependent mechanism. Redox Biol. 2021;48:102197.","journal-title":"Redox Biol"},{"key":"849_CR157","doi-asserted-by":"publisher","first-page":"e16095","DOI":"10.1111\/ene.16095","volume":"31","author":"M Bruno","year":"2024","unstructured":"Bruno M, Bonomi CG, Ricci F, Di Donna MG, Mercuri NB, Koch G, Martorana A, Motta C. Blood-brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer\u2019s disease. Eur J Neurol. 2024;31:e16095.","journal-title":"Eur J Neurol"},{"key":"849_CR158","doi-asserted-by":"crossref","unstructured":"Ali II, D\u2019Souza C, Singh J, Adeghate E. Adropin\u2019s Role in Energy Homeostasis and Metabolic Disorders. Int J Mol Sci 2022;23(15):8318.","DOI":"10.3390\/ijms23158318"},{"key":"849_CR159","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1161\/STROKEAHA.122.039628","volume":"54","author":"C Yang","year":"2023","unstructured":"Yang C, Liu L, Lavayen BP, Larochelle J, Gunraj RE, Butler AA, Candelario-Jalil E. Therapeutic benefits of Adropin in aged mice after transient ischemic stroke via reduction of Blood-Brain barrier damage. Stroke. 2023;54:234\u201344.","journal-title":"Stroke"},{"key":"849_CR160","doi-asserted-by":"crossref","unstructured":"Hasanpour-Segherlou Z, Butler AA, Candelario-Jalil E, Hoh BL. Role of the unique secreted peptide Adropin in various physiological and disease States. Biomolecules 2024;14(12):1613.","DOI":"10.3390\/biom14121613"},{"key":"849_CR161","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/jnc.14238","volume":"143","author":"L Yu","year":"2017","unstructured":"Yu L, Lu Z, Burchell S, Nowrangi D, Manaenko A, Li X, Xu Y, Xu N, Tang J, Dai H, Zhang JH. Adropin preserves the blood-brain barrier through a Notch1\/Hes1 pathway after intracerebral hemorrhage in mice. J Neurochem. 2017;143:750\u201360.","journal-title":"J Neurochem"},{"key":"849_CR162","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.redox.2018.06.003","volume":"18","author":"D Thapa","year":"2018","unstructured":"Thapa D, Stoner MW, Zhang M, Xie B, Manning JR, Guimaraes D, Shiva S, Jurczak MJ, Scott I. Adropin regulates pyruvate dehydrogenase in cardiac cells via a novel GPCR-MAPK-PDK4 signaling pathway. Redox Biol. 2018;18:25\u201332.","journal-title":"Redox Biol"},{"key":"849_CR163","doi-asserted-by":"publisher","first-page":"R511","DOI":"10.1152\/ajpregu.00517.2016","volume":"312","author":"SP Loewen","year":"2017","unstructured":"Loewen SP, Ferguson AV. Adropin acts in the rat paraventricular nucleus to influence neuronal excitability. Am J Physiol Regul Integr Comp Physiol. 2017;312:R511\u20139.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"849_CR164","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.metop.2024.100299","volume":"23","author":"S Rooban","year":"2024","unstructured":"Rooban S, Arul Senghor KA, Vinodhini VM, Kumar JS. Adropin: A crucial regulator of cardiovascular health and metabolic balance. Metabol Open. 2024;23:100299.","journal-title":"Metabol Open"},{"key":"849_CR165","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmolb.2016.00025","volume":"3","author":"S Shahjouei","year":"2016","unstructured":"Shahjouei S, Ansari S, Pourmotabbed T, Zand R. Potential roles of Adropin in central nervous system: review of current literature. Front Mol Biosci. 2016;3:25.","journal-title":"Front Mol Biosci"},{"key":"849_CR166","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1021\/acschemneuro.0c00637","volume":"11","author":"SM Moezzi","year":"2020","unstructured":"Moezzi SM, Mozafari N, Fazel-Hoseini SM, Nadimi-Parashkoohi S, Abbasi H, Ashrafi H, Azadi A. Apolipoprotein J in Alzheimer\u2019s disease: shedding light on its role with cell signaling pathway perspective and possible therapeutic approaches. ACS Chem Neurosci. 2020;11:4060\u201372.","journal-title":"ACS Chem Neurosci"},{"key":"849_CR167","doi-asserted-by":"crossref","unstructured":"Darwish NM, Al-Hail MK, Mohamed Y, Al Saady R, Mohsen S, Zar A, Al-Mansoori L, Pedersen S. The role of apolipoproteins in the commonest cancers: A review. Cancers 2023, 15.","DOI":"10.3390\/cancers15235565"},{"key":"849_CR168","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-150976","volume":"53","author":"C Merino-Zamorano","year":"2016","unstructured":"Merino-Zamorano C, Fern\u00e1ndez-de Retana S, Monta\u00f1ola A, Batlle A, Saint-Pol J, Mysiorek C, Gosselet F, Montaner J, Hern\u00e1ndez-Guillamon M. Modulation of Amyloid-\u03b21\u201340 transport by ApoA1 and ApoJ across an in vitro model of the Blood-Brain barrier. J Alzheimer\u2019s Disease: JAD. 2016;53:677\u201391.","journal-title":"J Alzheimer\u2019s Disease: JAD"},{"key":"849_CR169","doi-asserted-by":"publisher","first-page":"14637","DOI":"10.1038\/s41598-017-15215-w","volume":"7","author":"S Fern\u00e1ndez-de-Retana","year":"2017","unstructured":"Fern\u00e1ndez-de-Retana S, Cano-Sarabia M, Marazuela P, S\u00e1nchez-Quesada JL, Garcia-Leon A, Monta\u00f1ola A, Montaner J, Maspoch D, Hern\u00e1ndez-Guillamon M. Characterization of ApoJ-reconstituted high-density lipoprotein (rHDL) nanodisc for the potential treatment of cerebral \u03b2-amyloidosis. Sci Rep. 2017;7:14637.","journal-title":"Sci Rep"},{"key":"849_CR170","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1006\/bbrc.1994.2825","volume":"205","author":"BV Zlokovic","year":"1994","unstructured":"Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J. Brain uptake of Circulating apolipoproteins J and E complexed to Alzheimer\u2019s amyloid beta. Biochem Biophys Res Commun. 1994;205:1431\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"849_CR171","doi-asserted-by":"publisher","first-page":"117537","DOI":"10.1016\/j.jns.2021.117537","volume":"427","author":"T Romagnoli","year":"2021","unstructured":"Romagnoli T, Ortolani B, Sanz JM, Trentini A, Seripa D, Nora ED, Capatti E, Cervellati C, Passaro A, Zuliani G, Brombo G. Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia. J Neurol Sci. 2021;427:117537.","journal-title":"J Neurol Sci"},{"key":"849_CR172","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13195-019-0498-8","volume":"11","author":"SF de Retana","year":"2019","unstructured":"de Retana SF, Marazuela P, Sol\u00e9 M, Colell G, Bonaterra A, S\u00e1nchez-Quesada JL, Montaner J, Maspoch D, Cano-Sarabia M, Hern\u00e1ndez-Guillamon M. Peripheral administration of human Recombinant ApoJ\/clusterin modulates brain beta-amyloid levels in APP23 mice. Alzheimers Res Ther. 2019;11:42.","journal-title":"Alzheimers Res Ther"},{"key":"849_CR173","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/jnc.13491","volume":"136","author":"Z Huang","year":"2016","unstructured":"Huang Z, Cheng C, Jiang L, Yu Z, Cao F, Zhong J, Guo Z, Sun X. Intraventricular Apolipoprotein ApoJ infusion acts protectively in traumatic brain injury. J Neurochem. 2016;136:1017\u201325.","journal-title":"J Neurochem"},{"key":"849_CR174","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bbalip.2017.09.008","volume":"1863","author":"M Zandl-Lang","year":"2018","unstructured":"Zandl-Lang M, Fanaee-Danesh E, Sun Y, Albrecher NM, Gali CC, \u010can\u010dar I, Kober A, Tam-Amersdorfer C, Stracke A, Storck SM, et al. Regulatory effects of Simvastatin and ApoJ on APP processing and amyloid-\u03b2 clearance in blood-brain barrier endothelial cells. Biochim Et Biophys Acta Mol Cell Biology Lipids. 2018;1863:40\u201360.","journal-title":"Biochim Et Biophys Acta Mol Cell Biology Lipids"},{"key":"849_CR175","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF03036452","volume":"7","author":"MD Martin-Rehrmann","year":"2005","unstructured":"Martin-Rehrmann MD, Hoe HS, Capuani EM, Rebeck GW. Association of Apolipoprotein J-positive beta-amyloid plaques with dystrophic neurites in Alzheimer\u2019s disease brain. Neurotox Res. 2005;7:231\u201342.","journal-title":"Neurotox Res"},{"key":"849_CR176","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ. Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front NeuroSci. 2019;13:164.","journal-title":"Front NeuroSci"},{"key":"849_CR177","doi-asserted-by":"publisher","first-page":"e080373","DOI":"10.1002\/alz.080373","volume":"19","author":"G Milinkeviciute","year":"2023","unstructured":"Milinkeviciute G, Tran K, Da Cunha C, Mendoza-Arvilla A, Garcia-Agudo LF, Neumann J, Walker A, Kawauchi S, Tenner AJ, LaFerla F, et al. A CLU\/APOJ GWAS AD risk variant suppresses the astrocytic response to plaques and reduces axonal and neuritic damage in 5xFAD mice. Alzheimer\u2019s Dement. 2023;19:e080373.","journal-title":"Alzheimer\u2019s Dement"},{"key":"849_CR178","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s11064-020-03176-y","volume":"46","author":"VJ Balcar","year":"2021","unstructured":"Balcar VJ, Zeman T, Janout V, Janoutov\u00e1 J, Lochman J, \u0160er\u00fd O. Single nucleotide polymorphism rs11136000 of CLU gene (Clusterin, ApoJ) and the risk of Late-Onset Alzheimer\u2019s disease in a central European population. Neurochem Res. 2021;46:411\u201322.","journal-title":"Neurochem Res"},{"key":"849_CR179","doi-asserted-by":"publisher","first-page":"105765","DOI":"10.1016\/j.parkreldis.2023.105765","volume":"116","author":"W Paslawski","year":"2023","unstructured":"Paslawski W, Svenningsson P. Elevated ApoE, ApoJ and lipoprotein-bound \u03b1-synuclein levels in cerebrospinal fluid from Parkinson\u2019s disease patients - Validation in the BioFIND cohort. Parkinsonism Relat Disord. 2023;116:105765.","journal-title":"Parkinsonism Relat Disord"},{"key":"849_CR180","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike CJ. Sex and the development of Alzheimer\u2019s disease. J Neurosci Res. 2017;95:671\u201380.","journal-title":"J Neurosci Res"},{"key":"849_CR181","doi-asserted-by":"crossref","unstructured":"Qu X, Donnelly R. Sex Hormone-Binding Globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome. Int J Mol Sci 2020;21(21):8191.","DOI":"10.3390\/ijms21218191"},{"key":"849_CR182","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1749-6632.1997.tb48557.x","volume":"828","author":"M Levitz","year":"1997","unstructured":"Levitz M, Banerjee S, Raju U, Toniolo PG, Shore RE, Nachtigall LE. Sex hormone-binding Globulin in Estrogen-dependent cancer and Estrogen replacement therapy. Ann N Y Acad Sci. 1997;828:358\u201365.","journal-title":"Ann N Y Acad Sci"},{"key":"849_CR183","doi-asserted-by":"crossref","unstructured":"Raeisi-Dehkordi H, Amiri M, Rathmann W, Zeller T, Adamski J, Bano A, van der Schouw YT, Thorand B, Muka T, Nano J. Sex hormone-binding Globulin May explain sex differences for glucose homeostasis and incidence of type 2 diabetes: the KORA study. Eur J Epidemiol 2024.","DOI":"10.21203\/rs.3.rs-3459061\/v1"},{"key":"849_CR184","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/0960-0760(92)90455-R","volume":"42","author":"CJ Hobbs","year":"1992","unstructured":"Hobbs CJ, Jones RE, Plymate SR. The effects of sex hormone binding Globulin (SHBG) on testosterone transport into the cerebrospinal fluid. J Steroid Biochem Mol Biol. 1992;42:629\u201335.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"849_CR185","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2265.1985.tb01091.x","volume":"23","author":"R F\u00e4ssler","year":"1985","unstructured":"F\u00e4ssler R, Schwarz S, Pohl P. Demonstration of sex hormone binding Globulin in human cerebrospinal fluid. Clin Endocrinol. 1985;23:349\u201359.","journal-title":"Clin Endocrinol"},{"key":"849_CR186","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3389\/fgene.2019.00505","volume":"10","author":"C Liu","year":"2019","unstructured":"Liu C, Ma J, Zhang J, Zhao H, Zhu Y, Qi J, Liu L, Zhu L, Jiang Y, Tang G, et al. Testosterone deficiency caused by castration modulates mitochondrial biogenesis through the AR\/PGC1\u03b1\/TFAM pathway. Front Genet. 2019;10:505.","journal-title":"Front Genet"},{"key":"849_CR187","doi-asserted-by":"publisher","first-page":"1390915","DOI":"10.3389\/fnagi.2024.1390915","volume":"16","author":"T Zhang","year":"2024","unstructured":"Zhang T, Chu Y, Wang Y, Wang Y, Wang J, Ji X, Zhang G, Shi G, Cui R, Kang Y. Testosterone deficiency worsens mitochondrial dysfunction in APP\/PS1 mice. Front Aging Neurosci. 2024;16:1390915.","journal-title":"Front Aging Neurosci"},{"key":"849_CR188","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11306-023-02023-9","volume":"19","author":"S Li","year":"2023","unstructured":"Li S, Wang Y, Zhang X, Xiong X, Zhou F, Li X, Fan J, Liang X, Li G, Peng Y, Li Y. Mitochondrial damage-induced abnormal glucose metabolism with ageing in the hippocampus of APP\/PS1 mice. Metabolomics: Official J Metabolomic Soc. 2023;19:56.","journal-title":"Metabolomics: Official J Metabolomic Soc"},{"key":"849_CR189","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1007\/s12035-015-9315-y","volume":"53","author":"W Lv","year":"2016","unstructured":"Lv W, Du N, Liu Y, Fan X, Wang Y, Jia X, Hou X, Wang B. Low testosterone level and risk of Alzheimer\u2019s disease in the elderly men: a systematic review and Meta-Analysis. Mol Neurobiol. 2016;53:2679\u201384.","journal-title":"Mol Neurobiol"},{"key":"849_CR190","doi-asserted-by":"publisher","first-page":"113261","DOI":"10.1016\/j.biopha.2022.113261","volume":"153","author":"N Bourebaba","year":"2022","unstructured":"Bourebaba N, Ngo T, \u015amieszek A, Bourebaba L, Marycz K. Sex hormone binding Globulin as a potential drug candidate for liver-related metabolic disorders treatment. Biomed Pharmacother. 2022;153:113261.","journal-title":"Biomed Pharmacother"},{"key":"849_CR191","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1007\/s13760-024-02613-x","volume":"124","author":"C Geng","year":"2024","unstructured":"Geng C, Tang Y. Association between levels of sex hormones and risk of multiple sclerosis: a Mendelian randomization study. Acta Neurol Belgica. 2024;124:1913\u201322.","journal-title":"Acta Neurol Belgica"},{"key":"849_CR192","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/mus.21244","volume":"39","author":"LR Rodino-Klapac","year":"2009","unstructured":"Rodino-Klapac LR, Haidet AM, Kota J, Handy C, Kaspar BK, Mendell JR. Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease. Muscle Nerve. 2009;39:283\u201396.","journal-title":"Muscle Nerve"},{"key":"849_CR193","doi-asserted-by":"crossref","unstructured":"Sosa J, Oyelakin A, Sinha S. The reign of follistatin in tumors and their microenvironment: implications for drug resistance. Biology 2024, 13.","DOI":"10.3390\/biology13020130"},{"key":"849_CR194","doi-asserted-by":"crossref","unstructured":"Chen YJ, Deng SM, Chen HW, Tsao CH, Chen WT, Cheng SJ, Huang HS, Tan BC, Matzuk MM, Flint J, Huang GJ. Follistatin mediates learning and synaptic plasticity via regulation of Asic4 expression in the hippocampus. Proc Natl Acad Sci USA 2021;118(39):e2109040118.","DOI":"10.1073\/pnas.2109040118"},{"key":"849_CR195","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00592-024-02335-9","volume":"61","author":"X Miao","year":"2024","unstructured":"Miao X, Alidadipour A, Saed V, Sayyadi F, Jadidi Y, Davoudi M, Amraee F, Jadidi N, Afrisham R. Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation. Acta Diabetol. 2024;61:1339\u201361.","journal-title":"Acta Diabetol"},{"key":"849_CR196","doi-asserted-by":"publisher","first-page":"102093","DOI":"10.1016\/j.arr.2023.102093","volume":"92","author":"J Fessel","year":"2023","unstructured":"Fessel J. The several ways to authentically cure Alzheimer\u2019s dementia. Ageing Res Rev. 2023;92:102093.","journal-title":"Ageing Res Rev"},{"key":"849_CR197","doi-asserted-by":"crossref","unstructured":"Montgomery MK, Bayliss J, Devereux C, Bezawork-Geleta A, Roberts D, Huang C, Schittenhelm RB, Ryan A, Townley SL, Selth LA et al. SMOC1 is a glucose-responsive hepatokine and therapeutic target for glycemic control. Sci Transl Med 2020;12(559):eaaz8048.","DOI":"10.1126\/scitranslmed.aaz8048"},{"key":"849_CR198","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen PC, Yu K, Dey KK, Yarbro JM, Han X, Lutz BM, Rao S, et al. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron. 2020;105:975\u2013e991977.","journal-title":"Neuron"},{"key":"849_CR199","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s41562-024-01924-6","volume":"8","author":"Y Guo","year":"2024","unstructured":"Guo Y, Chen SD, You J, Huang SY, Chen YL, Zhang Y, Wang LB, He XY, Deng YT, Zhang YR, et al. Multiplex cerebrospinal fluid proteomics identifies biomarkers for diagnosis and prediction of Alzheimer\u2019s disease. Nat Hum Behav. 2024;8:2047\u201366.","journal-title":"Nat Hum Behav"},{"key":"849_CR200","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00401-024-02819-6","volume":"148","author":"K Balcomb","year":"2024","unstructured":"Balcomb K, Johnston C, Kavanagh T, Leitner D, Schneider J, Halliday G, Wisniewski T, Sunde M, Drummond E. SMOC1 colocalizes with Alzheimer\u2019s disease neuropathology and delays A\u03b2 aggregation. Acta Neuropathol. 2024;148:72.","journal-title":"Acta Neuropathol"},{"key":"849_CR201","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1038\/s41591-023-02476-4","volume":"29","author":"ECB Johnson","year":"2023","unstructured":"Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer\u2019s disease. Nat Med. 2023;29:1979\u201388.","journal-title":"Nat Med"},{"key":"849_CR202","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41593-024-01737-w","volume":"27","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette A, Gaiteri C, Wennstr\u00f6m M, Kumar A, Hristovska I, Spotorno N, Salvad\u00f3 G, Strandberg O, Mathys H, Tsai LH, et al. Proteomic changes in Alzheimer\u2019s disease associated with progressive A\u03b2 plaque and Tau tangle pathologies. Nat Neurosci. 2024;27:1880\u201391.","journal-title":"Nat Neurosci"},{"key":"849_CR203","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.4103\/NRR.NRR-D-24-00503","volume":"20","author":"A Gregory","year":"2025","unstructured":"Gregory A, Tang C, Fan F. Soluble epoxide hydrolase: a next-generation drug target for Alzheimer\u2019s disease and related dementias. Neural Regeneration Res. 2025;20:2585\u20136.","journal-title":"Neural Regeneration Res"},{"key":"849_CR204","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3389\/fnmol.2019.00325","volume":"12","author":"MF Domingues","year":"2019","unstructured":"Domingues MF, Callai-Silva N, Piovesan AR, Carlini CR. Soluble epoxide hydrolase and brain cholesterol metabolism. Front Mol Neurosci. 2019;12:325.","journal-title":"Front Mol Neurosci"},{"key":"849_CR205","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","volume":"111","author":"Y Wu","year":"2023","unstructured":"Wu Y, Dong JH, Dai YF, Zhu MZ, Wang MY, Zhang Y, Pan YD, Yuan XR, Guo ZX, Wang CX, et al. Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer\u2019s disease in mice. Neuron. 2023;111:2847\u2013e28622810.","journal-title":"Neuron"},{"key":"849_CR206","doi-asserted-by":"crossref","unstructured":"Ghosh A, Comerota MM, Wan D, Chen F, Propson NE, Hwang SH, Hammock BD, Zheng H. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer\u2019s disease. Sci Transl Med 2020;12(573):eabb1206.","DOI":"10.1126\/scitranslmed.abb1206"},{"key":"849_CR207","doi-asserted-by":"publisher","first-page":"4909","DOI":"10.1021\/acs.jmedchem.1c02150","volume":"65","author":"S Codony","year":"2022","unstructured":"Codony S, Pont C, Gri\u00f1\u00e1n-Ferr\u00e9 C, Di Pede-Mattatelli A, Calv\u00f3-Tusell C, Feixas F, Osuna S, Jarn\u00e9-Ferrer J, Naldi M, Bartolini M, et al. Discovery and in vivo proof of concept of a highly potent dual inhibitor of soluble epoxide hydrolase and acetylcholinesterase for the treatment of Alzheimer\u2019s disease. J Med Chem. 2022;65:4909\u201325.","journal-title":"J Med Chem"},{"key":"849_CR208","doi-asserted-by":"crossref","unstructured":"Tang C, Border JJ, Zhang H, Gregory A, Bai S, Fang X, Liu Y, Wang S, Hwang SH, Gao W et al. Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer\u2019s disease and diabetes-related dementia rat models. GeroScience 2025.","DOI":"10.1007\/s11357-025-01550-8"},{"key":"849_CR209","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1016\/j.neuron.2023.08.019","volume":"111","author":"Y Inoue","year":"2023","unstructured":"Inoue Y, Bamkole M, Kanekiyo T. Hepatic soluble epoxide hydrolase: A promising target for unveiling the liver-brain axis in Alzheimer\u2019s disease. Neuron. 2023;111:2775\u20137.","journal-title":"Neuron"},{"key":"849_CR210","doi-asserted-by":"publisher","first-page":"101234","DOI":"10.1016\/j.molmet.2021.101234","volume":"52","author":"JL Milstein","year":"2021","unstructured":"Milstein JL, Ferris HA. The brain as an insulin-sensitive metabolic organ. Mol Metabolism. 2021;52:101234.","journal-title":"Mol Metabolism"},{"key":"849_CR211","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s12192-021-01231-3","volume":"26","author":"E Razani","year":"2021","unstructured":"Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D. The PI3K\/Akt signaling axis in Alzheimer\u2019s disease: a valuable target to stimulate or suppress? Cell Stress Chaperones. 2021;26:871\u201387.","journal-title":"Cell Stress Chaperones"},{"key":"849_CR212","doi-asserted-by":"publisher","first-page":"102084","DOI":"10.1016\/j.arr.2023.102084","volume":"91","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Jabir MS, Albuhadily AK, Al-Gareeb AI, Rafeeq MF. The link between metabolic syndrome and alzheimer disease: A mutual relationship and long rigorous investigation. Ageing Res Rev. 2023;91:102084.","journal-title":"Ageing Res Rev"},{"key":"849_CR213","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1038\/s41467-022-29722-6","volume":"13","author":"H Xia","year":"2022","unstructured":"Xia H, Scholtes C, Dufour CR, Ouellet C, Ghahremani M, Gigu\u00e8re V. Insulin action and resistance are dependent on a GSK3\u03b2-FBXW7-ERR\u03b1 transcriptional axis. Nat Commun. 2022;13:2105.","journal-title":"Nat Commun"},{"key":"849_CR214","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.neubiorev.2021.10.009","volume":"131","author":"JD Iroegbu","year":"2021","unstructured":"Iroegbu JD, Ijomone OK, Femi-Akinlosotu OM, Ijomone OM. ERK\/MAPK signalling in the developing brain: perturbations and consequences. Neurosci Biobehavioral Reviews. 2021;131:792\u2013805.","journal-title":"Neurosci Biobehavioral Reviews"},{"key":"849_CR215","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Therapy. 2023;8:248.","journal-title":"Signal Transduct Target Therapy"},{"key":"849_CR216","doi-asserted-by":"publisher","first-page":"108907","DOI":"10.1016\/j.jnutbio.2021.108907","volume":"100","author":"C Gei\u00dfler","year":"2022","unstructured":"Gei\u00dfler C, Krause C, Neumann AM, Britsemmer JH, Taege N, Grohs M, Kaehler M, Cascorbi I, Lewis AG, Seeley RJ, et al. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice. J Nutr Biochem. 2022;100:108907.","journal-title":"J Nutr Biochem"},{"key":"849_CR217","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1210\/en.2012-1193","volume":"153","author":"J D\u00edaz-Delf\u00edn","year":"2012","unstructured":"D\u00edaz-Delf\u00edn J, Hondares E, Iglesias R, Giralt M, Caelles C, Villarroya F. TNF-\u03b1 represses \u03b2-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway. Endocrinology. 2012;153:4238\u201345.","journal-title":"Endocrinology"},{"key":"849_CR218","doi-asserted-by":"publisher","first-page":"e260424229342","DOI":"10.2174\/0115733998265915231116043813","volume":"21","author":"U Jain","year":"2025","unstructured":"Jain U, Srivastava P, Sharma A, Sinha S, Johari S. Impaired fibroblast growth factor 21 (FGF21) associated with visceral adiposity leads to insulin resistance: the core defect in diabetes mellitus. Curr Diabetes Rev. 2025;21:e260424229342.","journal-title":"Curr Diabetes Rev"},{"key":"849_CR219","doi-asserted-by":"crossref","unstructured":"Zhang X, Zheng H, Ni Z, Shen Y, Wang D, Li W, Zhao L, Li C, Gao H. Fibroblast growth factor 21 alleviates diabetes-induced cognitive decline. Cerebral cortex (New York, NY: 1991) 2024, 34.","DOI":"10.1093\/cercor\/bhad502"},{"key":"849_CR220","doi-asserted-by":"crossref","unstructured":"Jimenez V, Jambrina C, Casana E, Sacristan V, Mu\u00f1oz S, Darriba S, Rod\u00f3 J, Mallol C, Garcia M, Le\u00f3n X et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol Med 2018;10(8):e8791.","DOI":"10.15252\/emmm.201708791"},{"key":"849_CR221","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.2147\/DMSO.S383234","volume":"15","author":"M Hoang Thi","year":"2022","unstructured":"Hoang Thi M, Dang Thanh C, Huynh Quang T. The correlation between Angiopoietin-Like 3 and metabolic markers of some lipid and glucose in type 2 diabetes mellitus patients at the first diagnosis. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2022;15:3329\u201337.","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"key":"849_CR222","doi-asserted-by":"crossref","unstructured":"Arab Sadeghabadi Z, Nourbakhsh M, Alaee M, Nourbakhsh M, Ghorbanhosseini SS, Sharifi R, Razzaghy-Azar M. Angiopoietin-Like Proteins 2 and 3 in Children and Adolescents with Obesity and Their Relationship with Hypertension and Metabolic Syndrome. International Journal of Hypertension 2021, 2021:6748515.","DOI":"10.1155\/2021\/6748515"},{"key":"849_CR223","doi-asserted-by":"crossref","unstructured":"Alanbaei M, Abu-Farha M, Hebbar P, Melhem M, Chandy BS, Anoop E, Cherian P, Al-Khairi I, Alkayal F, Al-Mulla F et al. ANGPTL3 variants associate with lower levels of Irisin and C-Peptide in a cohort of Arab individuals. Genes 2021;12(5):755.","DOI":"10.3390\/genes12050755"},{"key":"849_CR224","doi-asserted-by":"crossref","unstructured":"Mukhuty A, Fouzder C, Kundu R. Fetuin-A secretion from \u03b2-cells leads to accumulation of macrophages in Islets, aggravates inflammation and impairs insulin secretion. J Cell Sci 2021;134(21):jcs258507.","DOI":"10.1242\/jcs.258507"},{"key":"849_CR225","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1002\/jcp.30121","volume":"236","author":"Y Chen","year":"2021","unstructured":"Chen Y, He X, Chen X, Li Y, Ke Y. SeP is elevated in NAFLD and participates in NAFLD pathogenesis through AMPK\/ACC pathway. J Cell Physiol. 2021;236:3800\u20137.","journal-title":"J Cell Physiol"},{"key":"849_CR226","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1089\/ars.2020.8087","volume":"33","author":"T Takamura","year":"2020","unstructured":"Takamura T. Hepatokine Selenoprotein P-Mediated reductive stress causes resistance to intracellular signal transduction. Antioxid Redox Signal. 2020;33:517\u201324.","journal-title":"Antioxid Redox Signal"},{"key":"849_CR227","doi-asserted-by":"crossref","unstructured":"Baneu P, V\u0103c\u0103rescu C, Dr\u0103gan SR, Cirin L, Laz\u0103r-H\u00f6cher AI, Cozgarea A, Faur-Grigori AA, Cri\u0219an S, Gai\u021b\u0103 D, Luca CT, Cozma D. The triglyceride\/hdl ratio as a surrogate biomarker for insulin resistance. Biomedicines 2024;12(7):1493.","DOI":"10.3390\/biomedicines12071493"},{"key":"849_CR228","doi-asserted-by":"crossref","unstructured":"Sidheeque Hassan V, Hanifa M, Navik U, Bali A. Exogenous fetuin-A protects against sepsis-induced myocardial injury by inhibiting oxidative stress and inflammation in mice. Fundam Clin Pharmacol. 2023;37:607\u201317.","DOI":"10.1111\/fcp.12870"},{"key":"849_CR229","doi-asserted-by":"crossref","unstructured":"Dogru T, Kirik A, Gurel H, Rizvi AA, Rizzo M, Sonmez A. The evolving role of Fetuin-A in nonalcoholic fatty liver disease: an overview from liver to the heart. Int J Mol Sci 2021;22(12):6627.","DOI":"10.3390\/ijms22126627"},{"key":"849_CR230","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/nu8030147","volume":"8","author":"PS Leung","year":"2016","unstructured":"Leung PS. The potential protective action of vitamin D in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients. 2016;8:147.","journal-title":"Nutrients"},{"key":"849_CR231","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1002\/jcp.30499","volume":"237","author":"A Mukhuty","year":"2022","unstructured":"Mukhuty A, Fouzder C, Kundu R. Fetuin-A excess expression amplifies lipid induced apoptosis and \u03b2-cell damage. J Cell Physiol. 2022;237:532\u201350.","journal-title":"J Cell Physiol"},{"key":"849_CR232","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s00125-021-05435-1","volume":"64","author":"F Gerst","year":"2021","unstructured":"Gerst F, Kemter E, Lorza-Gil E, Kaiser G, Fritz AK, Nano R, Piemonti L, Gauder M, Dahl A, Nadalin S, et al. The hepatokine fetuin-A disrupts functional maturation of pancreatic beta cells. Diabetologia. 2021;64:1358\u201374.","journal-title":"Diabetologia"},{"key":"849_CR233","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1530\/EC-20-0141","volume":"9","author":"K Ottarsdottir","year":"2020","unstructured":"Ottarsdottir K, Hellgren M, Bock D, Nilsson AG, Daka B. Longitudinal associations between sex hormone-binding Globulin and insulin resistance. Endocr Connections. 2020;9:418\u201325.","journal-title":"Endocr Connections"},{"key":"849_CR234","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/db19-26-OR","volume":"68","author":"SI Stone","year":"2019","unstructured":"Stone SI, Wegner DJ, Wambach JA, Cole FS, Ornitz DM, Urano F. 26-OR: digenic FGFR1\/KLB variants associated with endocrine specific FGF-21 signaling defects and extreme insulin resistance. Diabetes. 2019;68:26\u2013OR.","journal-title":"Diabetes"},{"key":"849_CR235","doi-asserted-by":"publisher","first-page":"4953","DOI":"10.1007\/s11033-019-04946-w","volume":"46","author":"C Feng","year":"2019","unstructured":"Feng C, Jin Z, Sun L, Wang X, Chi X, Zhang X, Lian S. Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells. Mol Biol Rep. 2019;46:4953\u201365.","journal-title":"Mol Biol Rep"},{"key":"849_CR236","doi-asserted-by":"publisher","first-page":"e00160","DOI":"10.1042\/BSR20140115","volume":"34","author":"A Tikka","year":"2014","unstructured":"Tikka A, Soronen J, Laurila PP, Metso J, Ehnholm C, Jauhiainen M. Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation. Biosci Rep. 2014;34:e00160.","journal-title":"Biosci Rep"},{"key":"849_CR237","doi-asserted-by":"crossref","unstructured":"Matuz-Mares D, Gonz\u00e1lez-Andrade M, Araiza-Villanueva MG, Vilchis-Landeros MM, V\u00e1zquez-Meza H. Mitochondrial calcium: effects of its imbalance in disease. Antioxid (Basel Switzerland) 2022;11(5):801.","DOI":"10.3390\/antiox11050801"},{"key":"849_CR238","doi-asserted-by":"crossref","unstructured":"Pires M, Rego AC. Apoe4 and Alzheimer\u2019s Disease Pathogenesis-Mitochondrial Deregulation and Targeted Therapeutic Strategies. Int J Mol Sci 2023;24(1):778.","DOI":"10.3390\/ijms24010778"},{"key":"849_CR239","doi-asserted-by":"crossref","unstructured":"Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci 2023;24(9):7898.","DOI":"10.3390\/ijms24097898"},{"key":"849_CR240","doi-asserted-by":"publisher","first-page":"1184079","DOI":"10.3389\/fonc.2023.1184079","volume":"13","author":"L Lin","year":"2023","unstructured":"Lin L, Wu Q, Lu F, Lei J, Zhou Y, Liu Y, Zhu N, Yu Y, Ning Z, She T, Hu M. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Front Oncol. 2023;13:1184079.","journal-title":"Front Oncol"},{"key":"849_CR241","doi-asserted-by":"crossref","unstructured":"Pensabene KM, LaMorte J, Allender AE, Wehr J, Kaur P, Savage M, Eggler AL. Acute oxidative stress can paradoxically suppress human NRF2 protein synthesis by inhibiting global protein translation. Antioxid (Basel Switzerland) 2023;12(9):1735.","DOI":"10.3390\/antiox12091735"},{"key":"849_CR242","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1007\/s11427-021-2067-7","volume":"65","author":"J Chen","year":"2022","unstructured":"Chen J, Jiang S, Shao H, Li B, Ji T, Staiculescu D, He J, Zhao J, Cai L, Liang X, et al. CRISPR-Cas9-based genome-wide screening identified novel targets for treating sorafenib-resistant hepatocellular carcinoma: a cross-talk between FGF21 and the NRF2 pathway. Sci China Life Sci. 2022;65:1998\u20132016.","journal-title":"Sci China Life Sci"},{"key":"849_CR243","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1007\/s12035-018-1234-2","volume":"56","author":"Z Yu","year":"2019","unstructured":"Yu Z, Lin L, Jiang Y, Chin I, Wang X, Li X, Lo EH, Wang X. Recombinant FGF21 protects against Blood-Brain barrier leakage through Nrf2 upregulation in type 2 diabetes mice. Mol Neurobiol. 2019;56:2314\u201327.","journal-title":"Mol Neurobiol"},{"key":"849_CR244","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12272-019-01188-z","volume":"43","author":"M Tsushima","year":"2020","unstructured":"Tsushima M, Liu J, Hirao W, Yamazaki H, Tomita H, Itoh K. Emerging evidence for crosstalk between Nrf2 and mitochondria in physiological homeostasis and in heart disease. Arch Pharm Res. 2020;43:286\u201396.","journal-title":"Arch Pharm Res"},{"key":"849_CR245","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2193-1801-3-2","volume":"3","author":"J M\u00e4kel\u00e4","year":"2014","unstructured":"M\u00e4kel\u00e4 J, Tselykh TV, Maiorana F, Eriksson O, Do HT, Mud\u00f2 G, Korhonen LT, Belluardo N, Lindholm D. Fibroblast growth factor-21 enhances mitochondrial functions and increases the activity of PGC-1\u03b1 in human dopaminergic neurons via Sirtuin-1. SpringerPlus. 2014;3:2.","journal-title":"SpringerPlus"},{"key":"849_CR246","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","volume":"146","author":"L Jin","year":"2022","unstructured":"Jin L, Geng L, Ying L, Shu L, Ye K, Yang R, Liu Y, Wang Y, Cai Y, Jiang X, et al. FGF21-Sirtuin 3 Axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity. Circulation. 2022;146:1537\u201357.","journal-title":"Circulation"},{"key":"849_CR247","doi-asserted-by":"publisher","first-page":"109452","DOI":"10.1016\/j.abb.2022.109452","volume":"732","author":"T-J Lee","year":"2022","unstructured":"Lee T-J, Nettleford SK, McGlynn A, Carlson BA, Kirimanjeswara GS, Prabhu KS. The role of selenoproteins in neutrophils during inflammation. Arch Biochem Biophys. 2022;732:109452.","journal-title":"Arch Biochem Biophys"},{"key":"849_CR248","doi-asserted-by":"publisher","first-page":"1201982","DOI":"10.3389\/fnagi.2023.1201982","volume":"15","author":"J Miao","year":"2023","unstructured":"Miao J, Ma H, Yang Y, Liao Y, Lin C, Zheng J, Yu M, Lan J. Microglia in Alzheimer\u2019s disease: pathogenesis, mechanisms, and therapeutic potentials. Front Aging Neurosci. 2023;15:1201982.","journal-title":"Front Aging Neurosci"},{"key":"849_CR249","doi-asserted-by":"publisher","first-page":"e14856","DOI":"10.1111\/cns.14856","volume":"30","author":"M AmeliMojarad","year":"2024","unstructured":"AmeliMojarad M, AmeliMojarad M. The neuroinflammatory role of microglia in Alzheimer\u2019s disease and their associated therapeutic targets. CNS Neurosci Ther. 2024;30:e14856.","journal-title":"CNS Neurosci Ther"},{"key":"849_CR250","doi-asserted-by":"publisher","first-page":"101397","DOI":"10.1016\/j.arr.2021.101397","volume":"70","author":"A Wi\u0119ckowska-Gacek","year":"2021","unstructured":"Wi\u0119ckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U. Western diet as a trigger of Alzheimer\u2019s disease: from metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration. Ageing Res Rev. 2021;70:101397.","journal-title":"Ageing Res Rev"},{"key":"849_CR251","doi-asserted-by":"publisher","first-page":"eadj7813","DOI":"10.1126\/sciadv.adj7813","volume":"10","author":"W Wang","year":"2024","unstructured":"Wang W, Li J, Cui S, Li J, Ye X, Wang Z, Zhang T, Jiang X, Kong Y, Chen X, et al. Microglial Ffar4 deficiency promotes cognitive impairment in the context of metabolic syndrome. Sci Adv. 2024;10:eadj7813.","journal-title":"Sci Adv"},{"key":"849_CR252","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH. Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation. 2023;46:1\u201317.","journal-title":"Inflammation"},{"key":"849_CR253","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1471-4159.2012.07660.x","volume":"120","author":"S Gupta","year":"2012","unstructured":"Gupta S, Knight AG, Gupta S, Keller JN, Bruce-Keller AJ. Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem. 2012;120:1060\u201371.","journal-title":"J Neurochem"},{"key":"849_CR254","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s12640-018-9914-2","volume":"34","author":"M Amiri","year":"2018","unstructured":"Amiri M, Braidy N, Aminzadeh M. Protective effects of fibroblast growth factor 21 against Amyloid-Beta(1\u201342)-Induced toxicity in SH-SY5Y cells. Neurotox Res. 2018;34:574\u201383.","journal-title":"Neurotox Res"},{"key":"849_CR255","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.18632\/aging.101086","volume":"8","author":"C R\u00fchlmann","year":"2016","unstructured":"R\u00fchlmann C, W\u00f6lk T, Bl\u00fcmel T, Stahn L, Vollmar B, Kuhla A. Long-term caloric restriction in ApoE-deficient mice results in neuroprotection via Fgf21-induced AMPK\/mTOR pathway. Aging. 2016;8:2777\u201389.","journal-title":"Aging"},{"key":"849_CR256","doi-asserted-by":"publisher","first-page":"843520","DOI":"10.3389\/fimmu.2022.843520","volume":"13","author":"ER Kim","year":"2022","unstructured":"Kim ER, Kim SR, Cho W, Lee SG, Kim SH, Kim JH, Choi E, Kim JH, Yu JW, Lee BW, et al. Short term isocaloric ketogenic diet modulates NLRP3 inflammasome via B-hydroxybutyrate and fibroblast growth factor 21. Front Immunol. 2022;13:843520.","journal-title":"Front Immunol"},{"key":"849_CR257","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.exger.2017.10.021","volume":"100","author":"J Zhang","year":"2017","unstructured":"Zhang J, Tong W, Sun H, Jiang M, Shen Y, Liu Y, Gu H, Guo J, Fang J, Jin L. Nrf2-mediated neuroprotection by MANF against 6-OHDA-induced cell damage via PI3K\/AKT\/GSK3\u03b2 pathway. Exp Gerontol. 2017;100:77\u201386.","journal-title":"Exp Gerontol"},{"key":"849_CR258","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.4103\/0366-6999.164983","volume":"128","author":"N Yang","year":"2015","unstructured":"Yang N, Qin Q. Apolipoprotein J: A new predictor and therapeutic target in cardiovascular disease?? Chin Med J. 2015;128:2530\u20134.","journal-title":"Chin Med J"},{"key":"849_CR259","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1042\/BCJ20210442","volume":"478","author":"D Chattopadhyay","year":"2021","unstructured":"Chattopadhyay D, Das S, Guria S, Basu S, Mukherjee S. Fetuin-A regulates adipose tissue macrophage content and activation in insulin resistant mice through MCP-1 and iNOS: involvement of IFN\u03b3-JAK2-STAT1 pathway. Biochem J. 2021;478:4027\u201343.","journal-title":"Biochem J"},{"key":"849_CR260","doi-asserted-by":"publisher","first-page":"448","DOI":"10.5551\/jat.No950","volume":"16","author":"H Takata","year":"2009","unstructured":"Takata H, Ikeda Y, Suehiro T, Ishibashi A, Inoue M, Kumon Y, Terada Y. High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1\/2 signaling pathway. J Atheroscler Thromb. 2009;16:448\u201356.","journal-title":"J Atheroscler Thromb"},{"key":"849_CR261","doi-asserted-by":"crossref","unstructured":"Lukiw WJ, Vergallo A, Lista S, Hampel H, Zhao Y. Biomarkers for Alzheimer\u2019s Disease (AD) and the Application of Precision Medicine. J Personalized Med 2020;10(3):138.","DOI":"10.3390\/jpm10030138"},{"key":"849_CR262","doi-asserted-by":"publisher","first-page":"kkad009","DOI":"10.1093\/psyrad\/kkad009","volume":"3","author":"C Dang","year":"2023","unstructured":"Dang C, Wang Y, Li Q, Lu Y. Neuroimaging modalities in the detection of Alzheimer\u2019s disease-associated biomarkers. Psychoradiology. 2023;3:kkad009.","journal-title":"Psychoradiology"},{"key":"849_CR263","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.neurobiolaging.2008.10.001","volume":"31","author":"M Muller","year":"2010","unstructured":"Muller M, Schupf N, Manly JJ, Mayeux R, Luchsinger JA. Sex hormone binding Globulin and incident Alzheimer\u2019s disease in elderly men and women. Neurobiol Aging. 2010;31:1758\u201365.","journal-title":"Neurobiol Aging"},{"key":"849_CR264","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/cen.12382","volume":"81","author":"GA Laughlin","year":"2014","unstructured":"Laughlin GA, McEvoy LK, Barrett-Connor E, Daniels LB, Ix JH. Fetuin-A, a new vascular biomarker of cognitive decline in older adults. Clin Endocrinol. 2014;81:134\u201340.","journal-title":"Clin Endocrinol"},{"key":"849_CR265","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s11357-020-00287-w","volume":"43","author":"M Conte","year":"2021","unstructured":"Conte M, Sabbatinelli J, Chiariello A, Martucci M, Santoro A, Monti D, Arcaro M, Galimberti D, Scarpini E, Bonfigli AR, et al. Disease-specific plasma levels of mitokines FGF21, GDF15, and humanin in type II diabetes and Alzheimer\u2019s disease in comparison with healthy aging. GeroScience. 2021;43:985\u20131001.","journal-title":"GeroScience"},{"key":"849_CR266","doi-asserted-by":"publisher","first-page":"639318","DOI":"10.3389\/fnagi.2021.639318","volume":"13","author":"XC Liu","year":"2021","unstructured":"Liu XC, Qi XH, Fang H, Zhou KQ, Wang QS, Chen GH. Increased MANF expression in the inferior Temporal gyrus in patients with alzheimer disease. Front Aging Neurosci. 2021;13:639318.","journal-title":"Front Aging Neurosci"},{"key":"849_CR267","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1530\/EC-19-0034","volume":"8","author":"W Yang","year":"2019","unstructured":"Yang W, Liu L, Wei Y, Fang C, Zhou F, Chen J, Han Q, Huang M, Tan X, Liu Q, et al. Exercise ameliorates the FGF21-adiponectin axis impairment in diet-induced obese mice. Endocr Connections. 2019;8:596\u2013604.","journal-title":"Endocr Connections"},{"key":"849_CR268","doi-asserted-by":"publisher","first-page":"101635","DOI":"10.1016\/j.redox.2020.101635","volume":"36","author":"Y Gao","year":"2020","unstructured":"Gao Y, Zhang W, Zeng LQ, Bai H, Li J, Zhou J, Zhou GY, Fang CW, Wang F, Qin XJ. Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy. Redox Biol. 2020;36:101635.","journal-title":"Redox Biol"},{"key":"849_CR269","doi-asserted-by":"publisher","first-page":"1059020","DOI":"10.3389\/fendo.2023.1059020","volume":"14","author":"M Arias-Calder\u00f3n","year":"2023","unstructured":"Arias-Calder\u00f3n M, Casas M, Balanta-Melo J, Morales-Jim\u00e9nez C, Hern\u00e1ndez N, Llanos P, Jaimovich E, Buvinic S. Fibroblast growth factor 21 is expressed and secreted from skeletal muscle following electrical stimulation via extracellular ATP activation of the PI3K\/Akt\/mTOR signaling pathway. Front Endocrinol. 2023;14:1059020.","journal-title":"Front Endocrinol"},{"key":"849_CR270","doi-asserted-by":"publisher","first-page":"155137","DOI":"10.1016\/j.metabol.2022.155137","volume":"129","author":"M Porflitt-Rodr\u00edguez","year":"2022","unstructured":"Porflitt-Rodr\u00edguez M, Guzm\u00e1n-Arriagada V, Sandoval-Valderrama R, Tam CS, Pavicic F, Ehrenfeld P, Mart\u00ednez-Huenchull\u00e1n S. Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review. Metab Clin Exp. 2022;129:155137.","journal-title":"Metab Clin Exp"},{"key":"849_CR271","doi-asserted-by":"publisher","first-page":"e0273527","DOI":"10.1371\/journal.pone.0273527","volume":"17","author":"XH Li","year":"2022","unstructured":"Li XH, Liu LZ, Chen L, Pan QN, Ouyang ZY, Fan DJ, Pan X, Lu SY, Luo QH, Tao PY, Huang HQ. Aerobic exercise regulates FGF21 and NLRP3 inflammasome-mediated pyroptosis and inhibits atherosclerosis in mice. PLoS ONE. 2022;17:e0273527.","journal-title":"PLoS ONE"},{"key":"849_CR272","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15605\/jafes.037.S4","volume":"38","author":"SM Oo","year":"2023","unstructured":"Oo SM, Htut MT, Htun YW, Mon AA, Kyaw MP. Lower plasma Selenoprotein P levels in regularly exercising young adults. J ASEAN Federation Endocr Soc. 2023;38:6\u201312.","journal-title":"J ASEAN Federation Endocr Soc"},{"key":"849_CR273","doi-asserted-by":"crossref","unstructured":"Mohr P, Hanna C, Powell A, Penman S, Blum K, Sharafshah A, Lewandrowski KU, Badgaiyan RD, Bowirrat A, Pinhasov A, Thanos PK. Selenoprotein P in a rodent model of exercise; theorizing its interaction with brain reward dysregulation, addictive behavior, and aging. J Personalized Med 2024;14(5):489.","DOI":"10.3390\/jpm14050489"},{"key":"849_CR274","doi-asserted-by":"publisher","first-page":"e14773","DOI":"10.14814\/phy2.14773","volume":"9","author":"G Ren","year":"2021","unstructured":"Ren G, Bowers RL, Kim T, Mahurin AJ, Grandjean PW, Mathews ST. Serum fetuin-A and Ser312 phosphorylated fetuin-A responses and markers of insulin sensitivity after a single bout of moderate intensity exercise. Physiological Rep. 2021;9:e14773.","journal-title":"Physiological Rep"},{"key":"849_CR275","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12944-018-0919-x","volume":"17","author":"A Khadir","year":"2018","unstructured":"Khadir A, Kavalakatt S, Madhu D, Hammad M, Devarajan S, Tuomilehto J, Tiss A. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis. 2018;17:291.","journal-title":"Lipids Health Dis"},{"key":"849_CR276","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4093\/dmj.2018.0160","volume":"44","author":"YK Jeon","year":"2020","unstructured":"Jeon YK, Kim SS, Kim JH, Kim HJ, Kim HJ, Park JJ, Cho YS, Joung SH, Kim JR, Kim BH, et al. Combined aerobic and resistance exercise training reduces Circulating Apolipoprotein J levels and improves insulin resistance in postmenopausal diabetic women. Diabetes Metabolism J. 2020;44:103\u201312.","journal-title":"Diabetes Metabolism J"},{"key":"849_CR277","first-page":"333","volume":"27","author":"N Bazhan","year":"2023","unstructured":"Bazhan N, Jakovleva TV, Kazantseva AY, Kostina NE, Orlov PE, Balybina NY, Baranov K, Makarova EN. Studying sex differences in responses to fibroblast growth factor 21 administration in obese mice consuming a sweet-fat diet. Vavilovskii Zhurnal Genetiki I Selektsii. 2023;27:333\u201341.","journal-title":"Vavilovskii Zhurnal Genetiki I Selektsii"},{"key":"849_CR278","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41387-024-00277-3","volume":"14","author":"W Guo","year":"2024","unstructured":"Guo W, Cao H, Shen Y, Li W, Wang W, Cheng L, Cai M, Xu F. Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis. Nutr Diabetes. 2024;14:18.","journal-title":"Nutr Diabetes"},{"key":"849_CR279","doi-asserted-by":"publisher","first-page":"967375","DOI":"10.3389\/fmed.2022.967375","volume":"9","author":"K Falamarzi","year":"2022","unstructured":"Falamarzi K, Malekpour M, Tafti MF, Azarpira N, Behboodi M, Zarei M. The role of FGF21 and its analogs on liver associated diseases. Front Med. 2022;9:967375.","journal-title":"Front Med"},{"key":"849_CR280","doi-asserted-by":"crossref","unstructured":"Wu T, Liu Q, Li Y, Li H, Chen L, Yang X, Tang Q, Pu S, Kuang J, Li R et al. Feeding-induced hepatokine, Manf, ameliorates diet-induced obesity by promoting adipose Browning via p38 MAPK pathway. J Exp Med 2021 7;218(6):e20201203.","DOI":"10.1084\/jem.20201203"},{"key":"849_CR281","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1210\/jcem.85.1.6291","volume":"85","author":"C Longcope","year":"2000","unstructured":"Longcope C, Feldman HA, McKinlay JB, Araujo AB. Diet and sex Hormone-Binding Globulin. J Clin Endocrinol Metabolism. 2000;85:293\u20136.","journal-title":"J Clin Endocrinol Metabolism"},{"key":"849_CR282","doi-asserted-by":"publisher","first-page":"2400020","DOI":"10.1002\/mnfr.202400020","volume":"68","author":"L Brianso-Llort","year":"2024","unstructured":"Brianso-Llort L, Sa\u00e9z-Lopez C, Alvarez-Guaita A, Ramos-Perez L, Hernandez C, Sim\u00f3 R, Selva DM. Recent advances on sex Hormone-Binding Globulin regulation by nutritional factors: clinical implications. Mol Nutr Food Res. 2024;68:2400020.","journal-title":"Mol Nutr Food Res"},{"key":"849_CR283","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1080\/10408398.2019.1631751","volume":"60","author":"MA Icer","year":"2020","unstructured":"Icer MA, Y\u0131ld\u0131ran H. Effects of nutritional status on serum fetuin-A level. Crit Rev Food Sci Nutr. 2020;60:1938\u201346.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"849_CR284","doi-asserted-by":"crossref","unstructured":"Zhang F, Li X, Wei Y. Selenium and selenoproteins in health. Biomolecules 2023;13(5):799.","DOI":"10.3390\/biom13050799"},{"key":"849_CR285","doi-asserted-by":"publisher","first-page":"1353626","DOI":"10.3389\/fphar.2024.1353626","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Li T, Tian X, An W, Wang Z, Han B, Tao H, Wang J, Wang X. Research progress on the pegylation of therapeutic proteins and peptides (TPPs). Front Pharmacol. 2024;15:1353626.","journal-title":"Front Pharmacol"},{"key":"849_CR286","doi-asserted-by":"crossref","unstructured":"Jiang Y, Lin L, Liu N, Wang Q, Yuan J, Li Y, Chung KK, Guo S, Yu Z, Wang X. FGF21 protects against aggravated Blood-Brain barrier disruption after ischemic focal stroke in diabetic Db\/db male mice via cerebrovascular PPAR\u03b3 activation. Int J Mol Sci 2020, 21.","DOI":"10.3390\/ijms21030824"},{"key":"849_CR287","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.xcrm.2020.100057","volume":"1","author":"A Kaufman","year":"2020","unstructured":"Kaufman A, Abuqayyas L, Denney WS, Tillman EJ, Rolph T. AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients. Cell Rep Med. 2020;1:100057.","journal-title":"Cell Rep Med"},{"key":"849_CR288","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1056\/NEJMoa2031049","volume":"383","author":"RS Rosenson","year":"2020","unstructured":"Rosenson RS, Burgess LJ, Ebenbichler CF, Baum SJ, Stroes ESG, Ali S, Khilla N, Hamlin R, Pordy R, Dong Y, et al. Evinacumab in patients with refractory hypercholesterolemia. N Engl J Med. 2020;383:2307\u201319.","journal-title":"N Engl J Med"},{"key":"849_CR289","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1038\/s41467-017-01863-z","volume":"8","author":"Y Mita","year":"2017","unstructured":"Mita Y, Nakayama K, Inari S, Nishito Y, Yoshioka Y, Sakai N, Sotani K, Nagamura T, Kuzuhara Y, Inagaki K, et al. Selenoprotein P-neutralizing antibodies improve insulin secretion and glucose sensitivity in type 2 diabetes mouse models. Nat Commun. 2017;8:1658.","journal-title":"Nat Commun"},{"key":"849_CR290","doi-asserted-by":"publisher","first-page":"117608","DOI":"10.1016\/j.biopha.2024.117608","volume":"180","author":"M Meroni","year":"2024","unstructured":"Meroni M, Dongiovanni P, Tiano F, Piciotti R, Alisi A, Panera N. \u03b2-Klotho as novel therapeutic target in metabolic Dysfunction-Associated steatotic liver disease (MASLD): A narrative review. Biomed Pharmacother. 2024;180:117608.","journal-title":"Biomed Pharmacother"},{"key":"849_CR291","doi-asserted-by":"publisher","first-page":"28992","DOI":"10.1073\/pnas.2012073117","volume":"117","author":"A Baruch","year":"2020","unstructured":"Baruch A, Wong C, Chinn LW, Vaze A, Sonoda J, Gelzleichter T, Chen S, Lewin-Koh N, Morrow L, Dheerendra S, et al. Antibody-mediated activation of the FGFR1\/Klotho\u03b2 complex corrects metabolic dysfunction and alters food preference in obese humans. Proc Natl Acad Sci USA. 2020;117:28992\u20139000.","journal-title":"Proc Natl Acad Sci USA"},{"key":"849_CR292","doi-asserted-by":"publisher","first-page":"21280","DOI":"10.1038\/s41598-020-77978-z","volume":"10","author":"JM Cho","year":"2020","unstructured":"Cho JM, Yang EH, Quan W, Nam EH, Cheon HG. Discovery of a novel fibroblast activation protein (FAP) inhibitor, BR103354, with anti-diabetic and anti-steatotic effects. Sci Rep. 2020;10:21280.","journal-title":"Sci Rep"},{"key":"849_CR293","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.gendis.2021.12.011","volume":"10","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wang Y, Liu J. Friend or foe for obesity: how hepatokines remodel adipose tissues and translational perspective. Genes Dis. 2023;10:825\u201347.","journal-title":"Genes Dis"},{"key":"849_CR294","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1093\/eurheartj\/ehaa689","volume":"41","author":"D Gaudet","year":"2020","unstructured":"Gaudet D, Karwatowska-Prokopczuk E, Baum SJ, Hurh E, Kingsbury J, Bartlett VJ, Figueroa AL, Piscitelli P, Singleton W, Witztum JL, et al. Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia. Eur Heart J. 2020;41:3936\u201345.","journal-title":"Eur Heart J"},{"key":"849_CR295","doi-asserted-by":"publisher","first-page":"655575","DOI":"10.3389\/fcvm.2021.655575","volume":"8","author":"J Yan","year":"2021","unstructured":"Yan J, Nie Y, Cao J, Luo M, Yan M, Chen Z, He B. The roles and Pharmacological effects of FGF21 in preventing Aging-Associated metabolic diseases. Front Cardiovasc Med. 2021;8:655575.","journal-title":"Front Cardiovasc Med"},{"key":"849_CR296","doi-asserted-by":"crossref","unstructured":"Liu XL, Yeerlan J, Liu Z, Bai Y, Wang Q, Yan Y, Xu L, Jia C, Zhang L: Past, Present, and Future of Liver-Brain Axis in Alzheimer\u2019s Disease: A Bibliometric Review. Journal of Alzheimer\u2019s Disease 2024, 101:1267\u20131280.","DOI":"10.3233\/JAD-240688"},{"key":"849_CR297","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener. 2022;17:72.","journal-title":"Mol Neurodegener"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00849-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00849-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T11:02:57Z","timestamp":1750330977000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00849-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":297,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["849"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00849-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"31 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}